<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>RMR2 Phased Study Design & Analysis Framework</title>
  <script src="https://cdn.tailwindcss.com"></script>
  <style>
    html { scroll-behavior: smooth; }
    body { font-family: system-ui, -apple-system, sans-serif; }
    .font-mono { font-family: ui-monospace, SFMono-Regular, "SF Mono", Menlo, Monaco, Consolas, monospace; }

    /* Tab styling */
    .tab-button {
      padding: 0.75rem 1.5rem;
      font-weight: 600;
      border-bottom: 3px solid transparent;
      transition: all 0.2s;
      cursor: pointer;
    }
    .tab-button:hover { background: #f1f5f9; }
    .tab-button.active {
      border-bottom-color: #6366f1;
      color: #4f46e5;
      background: #eef2ff;
    }
    .tab-content { display: none; }
    .tab-content.active { display: block; }

    /* Framework tab styles */
    table { border-collapse: collapse; width: 100%; margin: 1rem 0; }
    th, td { border: 1px solid #e2e8f0; padding: 0.5rem 0.75rem; text-align: left; }
    th { background-color: #f8fafc; font-weight: 600; }
    tr:nth-child(even) { background-color: #f8fafc; }

    .section { margin-bottom: 2.5rem; padding-top: 1rem; }
    .section h2 {
      font-size: 1.5rem;
      font-weight: 700;
      color: #1e293b;
      padding-bottom: 0.5rem;
      border-bottom: 2px solid #e2e8f0;
      margin-bottom: 1rem;
    }
    .section h3 { font-size: 1.15rem; font-weight: 600; color: #334155; margin-top: 1.5rem; margin-bottom: 0.75rem; }
    .section h4 { font-size: 1rem; font-weight: 600; color: #475569; margin-top: 1.25rem; margin-bottom: 0.5rem; }
    .section p { color: #475569; line-height: 1.7; margin-bottom: 0.75rem; }

    .callout { padding: 1rem 1.25rem; border-radius: 0.5rem; margin: 1rem 0; }
    .callout-amber { background: #fffbeb; border: 1px solid #fcd34d; }
    .callout-blue { background: #eff6ff; border: 1px solid #93c5fd; }
    .callout-green { background: #f0fdf4; border: 1px solid #86efac; }
    .callout-red { background: #fef2f2; border: 1px solid #fca5a5; }
    .callout-slate { background: #f8fafc; border: 1px solid #cbd5e1; }
    .callout-cyan { background: #ecf9ff; border: 1px solid #67e8f9; }

    .decision-tree {
      background: #f8fafc;
      border-left: 4px solid #6366f1;
      padding: 1rem 1.5rem;
      margin: 1rem 0;
      font-family: ui-monospace, monospace;
      font-size: 0.875rem;
      white-space: pre-wrap;
    }

    /* Diagram styles */
    .intervention-grid { display: grid; grid-template-columns: repeat(4, 1fr); gap: 0.5rem; }
    .intervention-card { background: #f5f3ff; border: 1px solid #c4b5fd; border-radius: 0.5rem; padding: 0.75rem; text-align: center; }
    .diagram-card { background: white; border: 1px solid #e2e8f0; border-radius: 0.75rem; padding: 1.5rem; margin: 1.5rem 0; box-shadow: 0 1px 3px rgba(0,0,0,0.05); }

    /* Framework navigation */
    .framework-nav {
      position: sticky;
      top: 60px;
      background: #f8fafc;
      border: 1px solid #e2e8f0;
      border-radius: 0.5rem;
      padding: 1rem;
      max-height: calc(100vh - 100px);
      overflow-y: auto;
    }
    .framework-nav a {
      display: block;
      padding: 0.25rem 0.5rem;
      color: #64748b;
      text-decoration: none;
      font-size: 0.8125rem;
      border-radius: 0.25rem;
    }
    .framework-nav a:hover { background: #e2e8f0; color: #334155; }
    .framework-nav a.nav-section { font-weight: 600; color: #334155; margin-top: 0.5rem; }

      /* Collapsible styling */
      details summary {
        list-style: none;
      }
      details summary::-webkit-details-marker {
        display: none;
      }
      details[open] summary .chevron {
        transform: rotate(90deg);
      }
      details summary:hover {
        filter: brightness(0.95);
      }
      .chevron {
        transition: transform 0.2s ease;
        display: inline-block;
      }
  </style>
</head>
<body class="bg-slate-50 text-slate-800">

  <!-- Header -->
  <div class="bg-white border-b border-slate-200 sticky top-0 z-50">
    <div class="max-w-6xl mx-auto px-6">
      <div class="flex items-center justify-between py-4">
        <div>
          <h1 class="text-xl font-bold text-slate-900">RMR2 Phased Study Design & Analysis Framework</h1>
          <p class="text-sm text-slate-500">LEV Foundation | February 2026</p>
        </div>
      </div>

      <!-- Tabs -->
      <div class="flex gap-1">
        <button class="tab-button active" onclick="showTab('diagram')">
          üìä Visual Overview
        </button>
        <button class="tab-button" onclick="showTab('framework')">
          üìÑ Detailed Framework
        </button>
        <button class="tab-button" onclick="showTab('whyx')">
          üîç Why X Might Not Add
        </button>
      </div>
    </div>
  </div>

  <!-- ==================== DIAGRAM TAB ==================== -->
  <div id="diagram-tab" class="tab-content active">
    <div class="max-w-6xl mx-auto p-6">

      <!-- Strategic Rationale Banner -->
      <div class="bg-amber-50 border border-amber-200 rounded-lg p-4 mb-6">
        <div class="flex items-start gap-3">
          <div class="bg-amber-400 text-white rounded-full w-8 h-8 flex items-center justify-center flex-shrink-0 mt-0.5">
            <span class="text-lg font-bold">!</span>
          </div>
          <div>
            <h3 class="font-semibold text-amber-900 mb-1">Strategic Rationale</h3>
            <p class="text-amber-800 text-sm mb-2">
              <strong>Rapamycin (r)</strong> is the benchmark‚Äîthe best-known mouse lifespan intervention (~25-30% extension).
              However, mTOR-axis interventions have not translated effectively to humans.
            </p>
            <p class="text-amber-800 text-sm">
              <strong>Goal:</strong> Find a combination <strong>E</strong> that significantly exceeds rapamycin (E &gt; r),
              ideally without requiring rapamycin (E ‚âà rE). This suggests the combination works through mechanisms
              distinct from rapamycin‚Äîbetter candidates for human translation.
            </p>
          </div>
        </div>
      </div>

      <!-- Epistemological Foundation -->
      <div class="bg-slate-100 border border-slate-300 rounded-lg p-4 mb-6">
        <h3 class="font-semibold text-slate-800 mb-2">Operating Principle: Mechanistic Uncertainty</h3>
        <p class="text-slate-700 text-sm mb-2">
          We lack complete mechanistic understanding of how <em>any</em> intervention extends lifespan.
          Rather than assume biology, we use <strong>empirical inference</strong> from outcomes.
        </p>
        <div class="bg-white rounded p-3 mt-2">
          <p class="text-sm text-slate-600">
            <strong>Operational definition of "functional rapalog":</strong> An intervention that provides no additional
            benefit when combined with rapamycin (rX ‚âà r), suggesting it achieves the same outcome through
            overlapping or redundant means‚Äîregardless of whether we know the mechanism.
          </p>
          <p class="text-sm text-slate-500 mt-2 italic">
            <strong>Caveat:</strong> rX ‚âà r does NOT automatically mean X is a functional rapalog.
            Structural masking (X addresses damage that isn't rate-limiting after r) or network masking (X's effects
            are blocked by r's network changes) can produce the same pattern. Secondary endpoints are diagnostic‚Äîsee Detailed Framework.
          </p>
        </div>
      </div>

      <!-- Main Flow -->
      <div class="space-y-6">

        <!-- Pilots Section -->
        <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6">
          <div class="flex items-center gap-3 mb-4">
            <div class="bg-violet-100 text-violet-700 px-3 py-1 rounded-full text-sm font-medium">Current Stage</div>
            <h2 class="text-xl font-semibold text-slate-800">Pilot Validation Studies</h2>
          </div>
          <p class="text-slate-600 mb-4">8 interventions ¬∑ Validation & de-risking before Phase 1</p>

          <div class="intervention-grid">
            <div class="intervention-card"><div class="text-xs text-violet-500 mb-1">X<sub>1</sub></div><div class="text-sm font-medium text-violet-800">OSK</div></div>
            <div class="intervention-card"><div class="text-xs text-violet-500 mb-1">X<sub>2</sub></div><div class="text-sm font-medium text-violet-800">d-PUFAs</div></div>
            <div class="intervention-card"><div class="text-xs text-violet-500 mb-1">X<sub>3</sub></div><div class="text-sm font-medium text-violet-800">Oxytocin</div></div>
            <div class="intervention-card"><div class="text-xs text-violet-500 mb-1">X<sub>4</sub></div><div class="text-sm font-medium text-violet-800">CASIN</div></div>
            <div class="intervention-card"><div class="text-xs text-violet-500 mb-1">X<sub>5</sub></div><div class="text-sm font-medium text-violet-800">Anti-IL-11</div></div>
            <div class="intervention-card"><div class="text-xs text-violet-500 mb-1">X<sub>6</sub></div><div class="text-sm font-medium text-violet-800">Exosomes</div></div>
            <div class="intervention-card"><div class="text-xs text-violet-500 mb-1">X<sub>7</sub></div><div class="text-sm font-medium text-violet-800">Senolytic</div></div>
            <div class="intervention-card"><div class="text-xs text-violet-500 mb-1">X<sub>8</sub></div><div class="text-sm font-medium text-violet-800">rMSA</div></div>
          </div>

          <div class="mt-4 p-3 bg-violet-50 rounded-lg">
            <p class="text-sm text-violet-700">
              <strong>Selection basis:</strong> Interventions chosen to address largely different types of damage (distinct primary targets)
              with known lifespan-extending effects‚Äîintentionally avoiding likely functional rapalogs.
            </p>
          </div>
        </div>

        <!-- Arrow -->
        <div class="flex justify-center">
          <div class="flex flex-col items-center text-slate-400">
            <div class="w-0.5 h-4 bg-slate-300"></div>
            <div class="text-xs text-slate-500 my-1">GO/NO-GO per intervention</div>
            <div class="w-0.5 h-4 bg-slate-300"></div>
            <svg class="w-4 h-4" fill="currentColor" viewBox="0 0 20 20"><path fill-rule="evenodd" d="M5.293 7.293a1 1 0 011.414 0L10 10.586l3.293-3.293a1 1 0 111.414 1.414l-4 4a1 1 0 01-1.414 0l-4-4a1 1 0 010-1.414z" clip-rule="evenodd" /></svg>
          </div>
        </div>

        <!-- Phase 1 Section -->
        <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6">
          <div class="flex items-center gap-3 mb-4">
            <div class="bg-blue-100 text-blue-700 px-3 py-1 rounded-full text-sm font-medium">Phase 1</div>
            <h2 class="text-xl font-semibold text-slate-800">Monotherapy & Full Combination Testing</h2>
          </div>
          <p class="text-slate-600 mb-6">1,200 mice ¬∑ 20 groups ¬∑ n=25-50 per sex per group</p>

          <div class="grid grid-cols-2 gap-6">
            <!-- Without Rapamycin -->
            <div class="space-y-3">
              <div class="text-center text-sm font-medium text-slate-500 pb-2 border-b border-slate-200">Without Rapamycin</div>
              <div class="bg-slate-100 border border-slate-300 rounded-lg p-3">
                <div class="flex justify-between items-center">
                  <span class="font-medium text-slate-700">C</span>
                  <span class="text-sm text-slate-500">Vehicle Control</span>
                  <span class="text-xs bg-slate-200 px-2 py-0.5 rounded">n=100</span>
                </div>
              </div>
              <div class="bg-blue-50 border border-blue-200 rounded-lg p-3">
                <div class="flex justify-between items-center mb-2">
                  <span class="font-medium text-blue-700">X<sub>1</sub> ‚Äì X<sub>8</sub></span>
                  <span class="text-sm text-blue-600">Monotherapies</span>
                  <span class="text-xs bg-blue-100 px-2 py-0.5 rounded">n=50 each</span>
                </div>
                <div class="text-xs text-blue-500">8 groups √ó 50 mice = 400 mice</div>
              </div>
              <div class="bg-emerald-50 border border-emerald-200 rounded-lg p-3">
                <div class="flex justify-between items-center">
                  <span class="font-medium text-emerald-700">E</span>
                  <span class="text-sm text-emerald-600">All 8 Combined</span>
                  <span class="text-xs bg-emerald-100 px-2 py-0.5 rounded">n=100</span>
                </div>
              </div>
            </div>

            <!-- With Rapamycin -->
            <div class="space-y-3">
              <div class="text-center text-sm font-medium text-amber-600 pb-2 border-b border-amber-200">With Rapamycin (benchmark modifier)</div>
              <div class="bg-amber-50 border border-amber-300 rounded-lg p-3">
                <div class="flex justify-between items-center">
                  <span class="font-medium text-amber-700">r</span>
                  <span class="text-sm text-amber-600">Rapamycin Only (benchmark)</span>
                  <span class="text-xs bg-amber-100 px-2 py-0.5 rounded">n=100</span>
                </div>
              </div>
              <div class="bg-orange-50 border border-orange-200 rounded-lg p-3">
                <div class="flex justify-between items-center mb-2">
                  <span class="font-medium text-orange-700">rX<sub>1</sub> ‚Äì rX<sub>8</sub></span>
                  <span class="text-sm text-orange-600">Mono + Rapa</span>
                  <span class="text-xs bg-orange-100 px-2 py-0.5 rounded">n=50 each</span>
                </div>
                <div class="text-xs text-orange-500">8 groups √ó 50 mice = 400 mice</div>
              </div>
              <div class="bg-rose-50 border border-rose-200 rounded-lg p-3">
                <div class="flex justify-between items-center">
                  <span class="font-medium text-rose-700">rE</span>
                  <span class="text-sm text-rose-600">All 8 + Rapa</span>
                  <span class="text-xs bg-rose-100 px-2 py-0.5 rounded">n=100</span>
                </div>
              </div>
            </div>
          </div>

          <!-- Phase 1 Summary -->
          <div class="mt-6 pt-4 border-t border-slate-200">
            <div class="flex justify-around text-center">
              <div><div class="text-2xl font-bold text-slate-800">20</div><div class="text-xs text-slate-500">Groups</div></div>
              <div><div class="text-2xl font-bold text-slate-800">1,200</div><div class="text-xs text-slate-500">Total Mice</div></div>
              <div><div class="text-2xl font-bold text-slate-800">600</div><div class="text-xs text-slate-500">Per Sex</div></div>
            </div>
          </div>
        </div>

        <!-- Operating Principle Section -->
        <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6">
          <h3 class="font-semibold text-slate-800 mb-4">1.4 The Damage Network</h3>
          <p class="text-slate-600 mb-4">
            Aging involves multiple damage types that are <strong>interconnected rather than independent</strong>. Damage type A may accelerate B; B may accelerate C; C may feed back to A. Interventions have primary targets, but effects propagate through this network via crosstalk and knock-on effects.
          </p>

          <div class="bg-cyan-50 border border-cyan-200 rounded-lg p-4 mb-4">
            <h4 class="font-semibold text-cyan-800 mb-3">Critical Implications</h4>
            <ul class="list-disc ml-6 text-sm text-cyan-900 space-y-2">
              <li>An intervention addressing damage type A may extend lifespan even if A is not itself rate-limiting, provided A's downstream effects include rate-limiting damage types</li>
              <li>An intervention may appear to "overlap" with rapamycin not because they share a molecular target, but because their effects converge through network propagation</li>
              <li>The position of a damage type in the network (upstream hub vs. peripheral node) matters as much as whether it is rate-limiting</li>
              <li>Interventions affecting upstream hubs that cascade to multiple rate-limiters have higher potential value than those addressing peripheral nodes</li>
            </ul>
          </div>

          <p class="text-sm text-slate-600 mb-4 italic">
            We cannot map the full mouse damage network, let alone the human one. But we can use empirical signals to infer network relationships and make probabilistic judgments about translation potential.
          </p>

          <div class="bg-slate-100 rounded-lg p-4">
            <h4 class="font-semibold text-slate-800 mb-3 text-sm">Network Position Terminology</h4>
            <table class="text-sm">
              <thead><tr><th>Term</th><th>Definition</th></tr></thead>
              <tbody>
                <tr><td><strong>Upstream hub</strong></td><td>Damage type whose accumulation drives multiple downstream damage types; addressing it has broad effects</td></tr>
                <tr><td><strong>Downstream node</strong></td><td>Damage type driven by upstream processes; addressing it may have limited effect if upstream drivers continue</td></tr>
                <tr><td><strong>Peripheral node</strong></td><td>Damage type with limited connections; addressing it affects only itself unless it happens to be rate-limiting</td></tr>
                <tr><td><strong>Cascade</strong></td><td>The propagation of an intervention's effects through network connections (knock-on effects)</td></tr>
              </tbody>
            </table>
          </div>
        </div>

        <!-- Secondary Endpoints Section -->
        <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6">
          <h3 class="font-semibold text-slate-800 mb-4">Data Collection: Beyond Lifespan</h3>
          <p class="text-sm text-slate-600 mb-4">
            While lifespan is the primary endpoint, extensive secondary data enables earlier signal detection,
            richer interpretation of ambiguous results, and post-hoc mechanistic analysis.
          </p>

          <div class="grid grid-cols-3 gap-4">
            <div class="bg-indigo-50 border border-indigo-200 rounded-lg p-4">
              <h4 class="font-medium text-indigo-800 mb-2 text-sm">Functional Assessments</h4>
              <ul class="text-xs text-indigo-700 space-y-1">
                <li>‚Ä¢ Grip strength</li>
                <li>‚Ä¢ Running wheel activity</li>
                <li>‚Ä¢ Cognitive tests (Barnes maze)</li>
                <li>‚Ä¢ Motor coordination (rotarod)</li>
              </ul>
              <div class="mt-2 pt-2 border-t border-indigo-200"><span class="text-xs text-indigo-600 italic">Longitudinal, in-life</span></div>
            </div>
            <div class="bg-teal-50 border border-teal-200 rounded-lg p-4">
              <h4 class="font-medium text-teal-800 mb-2 text-sm">Clinical Evaluation</h4>
              <ul class="text-xs text-teal-700 space-y-1">
                <li>‚Ä¢ Frailty index assessments</li>
                <li>‚Ä¢ Body weight tracking</li>
                <li>‚Ä¢ CBC & blood chemistries</li>
                <li>‚Ä¢ Glucose tolerance testing</li>
              </ul>
              <div class="mt-2 pt-2 border-t border-teal-200"><span class="text-xs text-teal-600 italic">Longitudinal, in-life</span></div>
            </div>
            <div class="bg-fuchsia-50 border border-fuchsia-200 rounded-lg p-4">
              <h4 class="font-medium text-fuchsia-800 mb-2 text-sm">Tissue Banking</h4>
              <ul class="text-xs text-fuchsia-700 space-y-1">
                <li>‚Ä¢ Full necropsy at death</li>
                <li>‚Ä¢ Blood & all tissues banked</li>
                <li>‚Ä¢ Enables post-hoc analysis:</li>
                <li class="pl-2">- mTOR markers, epi clocks</li>
                <li class="pl-2">- Senescence, inflammation</li>
              </ul>
              <div class="mt-2 pt-2 border-t border-fuchsia-200"><span class="text-xs text-fuchsia-600 italic">Terminal & interim</span></div>
            </div>
          </div>

          <div class="mt-4 p-3 bg-slate-100 rounded-lg">
            <p class="text-sm text-slate-700">
              <strong>Strategic value:</strong> Secondary endpoints are <em>diagnostic</em> for distinguishing overlap from masking and network masking
              when rX ‚âà r on lifespan. If X improves its target biomarkers in rX (vs r), X is working‚Äîit's just masked.
            </p>
          </div>
        </div>

        <!-- Analysis Framework -->
        <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6">
          <h3 class="font-semibold text-slate-800 mb-4">Phase 1 Analysis Framework</h3>

          <div class="grid grid-cols-2 gap-6">
            <!-- Individual Level -->
            <div class="space-y-3">
              <h4 class="font-medium text-slate-700 text-sm border-b pb-2">Individual Intervention Analysis</h4>
              <div class="space-y-2 text-sm">
                <div class="flex items-center gap-2 p-2 bg-slate-50 rounded">
                  <span class="font-mono text-slate-600 w-16 flex-shrink-0">X vs C</span>
                  <span class="text-slate-500">‚Üí</span>
                  <span class="text-slate-700">Does X have any independent effect?</span>
                </div>
                <div class="flex items-center gap-2 p-2 bg-slate-50 rounded">
                  <span class="font-mono text-slate-600 w-16 flex-shrink-0">X vs r</span>
                  <span class="text-slate-500">‚Üí</span>
                  <span class="text-slate-700">How does X compare to benchmark?</span>
                </div>
                <div class="flex items-center gap-2 p-2 bg-blue-50 rounded border border-blue-200">
                  <span class="font-mono text-blue-700 font-semibold w-16 flex-shrink-0">rX vs r</span>
                  <span class="text-blue-500">‚Üí</span>
                  <span class="text-blue-800">Does X add to rapamycin? <strong>(Key test)</strong></span>
                </div>
              </div>
            </div>

            <!-- Combination Level -->
            <div class="space-y-3">
              <h4 class="font-medium text-slate-700 text-sm border-b pb-2">Combination Analysis</h4>
              <div class="space-y-2 text-sm">
                <div class="flex items-center gap-2 p-2 bg-emerald-50 rounded border border-emerald-200">
                  <span class="font-mono text-emerald-700 font-semibold w-16 flex-shrink-0">E vs r</span>
                  <span class="text-emerald-500">‚Üí</span>
                  <span class="text-emerald-800">Does combination beat rapamycin? <strong>(Primary goal)</strong></span>
                </div>
                <div class="flex items-center gap-2 p-2 bg-purple-50 rounded border border-purple-200">
                  <span class="font-mono text-purple-700 font-semibold w-16 flex-shrink-0">rE vs E</span>
                  <span class="text-purple-500">‚Üí</span>
                  <span class="text-purple-800">Does rapamycin add to combination? <strong>(Translation signal)</strong></span>
                </div>
                <div class="flex items-center gap-2 p-2 bg-slate-50 rounded">
                  <span class="font-mono text-slate-600 w-16 flex-shrink-0">rE vs r</span>
                  <span class="text-slate-500">‚Üí</span>
                  <span class="text-slate-700">Does combination contribute beyond rapamycin?</span>
                </div>
              </div>
            </div>
          </div>

          <div class="mt-4 p-3 bg-slate-100 rounded-lg">
            <p class="text-sm text-slate-700">
              <strong>Cross-referencing logic:</strong> Individual patterns (rX vs r) generate hypotheses about which
              interventions may be functional rapalogs. Combination patterns (E, rE) test whether those hypotheses matter at scale.
            </p>
          </div>
        </div>

        <!-- Scenario Interpretation -->
        <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6">
          <h3 class="font-semibold text-slate-800 mb-4">Interpreting Individual Patterns: rX vs r</h3>

          <div class="space-y-3">
            <!-- rX > r -->
            <div class="p-4 bg-green-50 border border-green-200 rounded-lg">
              <div class="flex items-center gap-3 mb-2">
                <span class="font-mono font-bold text-green-700 text-lg">rX &gt; r</span>
                <span class="text-green-600 font-medium">Synergy with rapamycin</span>
              </div>
              <p class="text-sm text-green-800 mb-2">X adds benefit beyond rapamycin alone. Suggests X acts through pathway independent of mTOR inhibition.</p>
              <div class="text-xs text-green-700 bg-green-100 px-2 py-1 rounded inline-block">‚úì Keep in combination ‚Äî promising for translation</div>
            </div>

            <!-- rX ‚âà r -->
            <div class="p-4 bg-amber-50 border border-amber-200 rounded-lg">
              <div class="flex items-center gap-3 mb-2">
                <span class="font-mono font-bold text-amber-700 text-lg">rX ‚âà r</span>
                <span class="text-amber-600 font-medium">No additional benefit</span>
              </div>
              <p class="text-sm text-amber-800 mb-2"><strong>Three competing explanations:</strong></p>
              <div class="grid grid-cols-3 gap-2 mb-2">
                <div class="bg-red-100 p-2 rounded text-xs border border-red-200">
                  <strong class="text-red-900">1. Target overlap:</strong>
                  <span class="text-red-800"> X works through same/similar pathway as rapamycin</span>
                  <div class="mt-1 text-red-600 font-medium">Translation: Poor</div>
                </div>
                <div class="bg-green-100 p-2 rounded text-xs border border-green-200">
                  <strong class="text-green-900">2. Damage-type masking:</strong>
                  <span class="text-green-800"> X works independently, but addresses damage not rate-limiting after r</span>
                  <div class="mt-1 text-green-600 font-medium">Translation: Good</div>
                </div>
                <div class="bg-purple-100 p-2 rounded text-xs border border-purple-200">
                  <strong class="text-purple-900">3. Network masking:</strong>
                  <span class="text-purple-800"> X's effects propagate through nodes that r has already addressed</span>
                  <div class="mt-1 text-purple-600 font-medium">Translation: Good (humans lack r)</div>
                </div>
              </div>
              <div class="text-xs text-amber-700 bg-amber-100 px-2 py-1 rounded inline-block">? Do NOT auto-classify as rapalog ‚Äî use secondary endpoints to distinguish</div>
            </div>

            <!-- rX < r -->
            <div class="p-4 bg-red-50 border border-red-200 rounded-lg">
              <div class="flex items-center gap-3 mb-2">
                <span class="font-mono font-bold text-red-700 text-lg">rX &lt; r</span>
                <span class="text-red-600 font-medium">Antagonism with rapamycin</span>
              </div>
              <p class="text-sm text-red-800 mb-2">X actively reduces rapamycin's benefit. Could indicate pharmacological interference or biological counter-regulation.</p>
              <div class="text-xs text-red-700 bg-red-100 px-2 py-1 rounded inline-block">‚úó Test E-X and rE-X ‚Äî likely dragging down combination</div>
            </div>
          </div>

          <!-- Distinguishing explanations -->
          <div class="mt-4 p-4 bg-slate-100 rounded-lg">
            <h4 class="font-medium text-slate-800 mb-2 text-sm">Distinguishing the Three Explanations (when rX ‚âà r)</h4>
            <div class="space-y-2 text-sm text-slate-700">
              <div class="flex items-start gap-2">
                <span class="text-slate-400">1.</span>
                <span><strong>Biomarker analysis:</strong> Does rX show improved biomarkers for X's target vs r? Yes ‚Üí Masking/Network. No ‚Üí Possibly overlap.</span>
              </div>
              <div class="flex items-start gap-2">
                <span class="text-slate-400">2.</span>
                <span><strong>mTOR pathway markers:</strong> Does X affect p-S6K1, p-4EBP1? Yes ‚Üí Target overlap. No ‚Üí X is mechanistically independent.</span>
              </div>
              <div class="flex items-start gap-2">
                <span class="text-slate-400">3.</span>
                <span><strong>Cause-of-death analysis:</strong> Does r shift COD distribution differently than X? Different shifts ‚Üí supports masking/network masking.</span>
              </div>
              <div class="flex items-start gap-2">
                <span class="text-slate-400">4.</span>
                <span><strong>Cross-intervention pattern:</strong> If most/all rX ‚âà r ‚Üí ceiling or network effects. If only specific rX ‚âà r ‚Üí those X's may overlap.</span>
              </div>
            </div>
            <div class="mt-3 p-2 bg-green-100 rounded text-xs text-green-800 border border-green-200">
              <strong>Key insight:</strong> Masking or network masking means X may still work in humans where the damage hierarchy or network topology differs.
            </div>
          </div>
        </div>

        <!-- Decision Tree -->
        <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6">
          <h3 class="font-semibold text-slate-800 mb-4">Phase 1 ‚Üí Phase 2 Decision Logic</h3>

          <!-- Primary Decision: E vs r -->
          <div class="space-y-4">
            <div class="border-l-4 border-emerald-500 pl-4">
              <h4 class="font-medium text-slate-800 mb-2">Primary Question: E vs r</h4>
              <div class="space-y-2">
                <div class="flex items-start gap-2 p-2 bg-emerald-50 rounded">
                  <span class="font-mono text-emerald-700 font-bold w-20 flex-shrink-0">E &gt; r</span>
                  <div>
                    <span class="text-emerald-800 font-medium">PRIMARY GOAL ACHIEVED</span>
                    <p class="text-xs text-emerald-700 mt-1">Proceed to optimization: which X's are essential vs. passengers?</p>
                  </div>
                </div>
                <div class="flex items-start gap-2 p-2 bg-amber-50 rounded">
                  <span class="font-mono text-amber-700 font-bold w-20 flex-shrink-0">E ‚âà r</span>
                  <div>
                    <span class="text-amber-800 font-medium">Combination matches but doesn't beat benchmark</span>
                    <p class="text-xs text-amber-700 mt-1">Look for redundancy or antagonism among interventions</p>
                  </div>
                </div>
                <div class="flex items-start gap-2 p-2 bg-red-50 rounded">
                  <span class="font-mono text-red-700 font-bold w-20 flex-shrink-0">E &lt; r</span>
                  <div>
                    <span class="text-red-800 font-medium">Combination underperforms ‚Äî something is wrong</span>
                    <p class="text-xs text-red-700 mt-1">Investigate interactions; prioritize E-X testing for interventions where rX ‚â§ r</p>
                  </div>
                </div>
              </div>
            </div>

            <div class="border-l-4 border-purple-500 pl-4">
              <h4 class="font-medium text-slate-800 mb-2">Translation Signal: rE vs E</h4>
              <div class="space-y-2">
                <div class="flex items-start gap-2 p-2 bg-purple-50 rounded">
                  <span class="font-mono text-purple-700 font-bold w-20 flex-shrink-0">rE &gt;&gt; E</span>
                  <div>
                    <span class="text-purple-800 font-medium">Rapamycin adds substantial value</span>
                    <p class="text-xs text-purple-700 mt-1">Combination alone may be insufficient; combination doesn't fully cover rapamycin's mechanisms</p>
                  </div>
                </div>
                <div class="flex items-start gap-2 p-2 bg-green-50 rounded border border-green-200">
                  <span class="font-mono text-green-700 font-bold w-20 flex-shrink-0">rE ‚âà E</span>
                  <div>
                    <span class="text-green-800 font-medium">Rapamycin adds nothing ‚Äî IDEAL for translation</span>
                    <p class="text-xs text-green-700 mt-1">Combination covers rapamycin's function through (presumably) different mechanisms</p>
                  </div>
                </div>
                <div class="flex items-start gap-2 p-2 bg-red-50 rounded">
                  <span class="font-mono text-red-700 font-bold w-20 flex-shrink-0">rE &lt; E</span>
                  <div>
                    <span class="text-red-800 font-medium">Rapamycin antagonizes combination (surprising)</span>
                    <p class="text-xs text-red-700 mt-1">Investigate which components conflict with rapamycin</p>
                  </div>
                </div>
              </div>
            </div>
          </div>

          <!-- Best Case -->
          <div class="mt-6 p-4 bg-gradient-to-r from-green-50 to-emerald-50 border border-green-300 rounded-lg">
            <h4 class="font-semibold text-green-800 mb-2">Best Case Scenario</h4>
            <div class="flex items-center gap-4">
              <div class="font-mono text-lg text-green-700 font-bold">E &gt;&gt; r</div>
              <span class="text-green-600">AND</span>
              <div class="font-mono text-lg text-green-700 font-bold">E ‚â• rE</div>
            </div>
            <p class="text-sm text-green-700 mt-2">
              Combination dramatically exceeds rapamycin benchmark, and rapamycin doesn't add value.
              Strong candidate for human translation‚Äîeffects likely achieved through non-mTOR mechanisms.
            </p>
          </div>
        </div>

        <!-- Arrow to Phase 2 -->
        <div class="flex justify-center">
          <div class="flex flex-col items-center text-slate-400">
            <div class="w-0.5 h-6 bg-slate-300"></div>
            <svg class="w-4 h-4" fill="currentColor" viewBox="0 0 20 20"><path fill-rule="evenodd" d="M5.293 7.293a1 1 0 011.414 0L10 10.586l3.293-3.293a1 1 0 111.414 1.414l-4 4a1 1 0 01-1.414 0l-4-4a1 1 0 010-1.414z" clip-rule="evenodd" /></svg>
          </div>
        </div>

        <!-- Phase 2 Section -->
        <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6">
          <div class="flex items-center gap-3 mb-4">
            <div class="bg-purple-100 text-purple-700 px-3 py-1 rounded-full text-sm font-medium">Phase 2</div>
            <h2 class="text-xl font-semibold text-slate-800">Subtractive Combination Testing</h2>
            <span class="text-sm text-slate-400">(Conditional on Phase 1 results)</span>
          </div>

          <div class="grid grid-cols-2 gap-4 mb-4">
            <div class="bg-purple-50 border border-purple-200 rounded-lg p-4">
              <div class="font-medium text-purple-800 mb-2">E ‚Äì X<sub>i</sub></div>
              <div class="text-sm text-purple-600">Full combination minus intervention i</div>
            </div>
            <div class="bg-purple-50 border border-purple-200 rounded-lg p-4">
              <div class="font-medium text-purple-800 mb-2">rE ‚Äì X<sub>i</sub></div>
              <div class="text-sm text-purple-600">Full combination + rapa minus intervention i</div>
            </div>
          </div>

          <div class="space-y-2 text-sm">
            <h4 class="font-medium text-slate-700">Phase 2 triggers:</h4>
            <div class="grid grid-cols-1 gap-2">
              <div class="flex items-start gap-2 p-2 bg-slate-50 rounded">
                <span class="text-green-600 font-bold">If E &gt; r, E ‚âà rE:</span>
                <span class="text-slate-700">Test E-X<sub>i</sub> to find <em>minimal effective combination</em> (optimization)</span>
              </div>
              <div class="flex items-start gap-2 p-2 bg-slate-50 rounded">
                <span class="text-amber-600 font-bold">If E underperforms:</span>
                <span class="text-slate-700">Test E-X<sub>i</sub> to find <em>antagonists</em> (prioritize X where rX ‚â§ r)</span>
              </div>
              <div class="flex items-start gap-2 p-2 bg-slate-50 rounded">
                <span class="text-purple-600 font-bold">If specific pairs suspected:</span>
                <span class="text-slate-700">Consider targeted pair testing (X<sub>i</sub> + X<sub>j</sub>) or double subtractions</span>
              </div>
            </div>
          </div>

          <div class="mt-4 pt-3 border-t border-purple-200 text-center">
            <span class="text-sm text-purple-700">~800 additional mice (variable based on Phase 1 results)</span>
          </div>
        </div>

        <!-- Limitations Note -->
        <div class="bg-slate-100 border border-slate-300 rounded-lg p-4">
          <h3 class="font-semibold text-slate-700 mb-2 text-sm">Design Limitations & Considerations</h3>
          <div class="grid grid-cols-4 gap-3 text-xs text-slate-600">
            <div>
              <strong class="text-slate-700">Higher-order interactions:</strong> Pairwise X<sub>i</sub>-X<sub>j</sub> antagonism
              cannot be detected in Phase 1‚Äîonly visible through E underperformance.
            </div>
            <div>
              <strong class="text-slate-700">Statistical power:</strong> With n=50 per monotherapy group, detecting
              small effect size differences (5-10%) may be challenging.
            </div>
            <div>
              <strong class="text-slate-700">Masking/Network effects:</strong> rX ‚âà r may reflect masking or network masking rather than overlap.
              Secondary endpoints and COD analysis are diagnostic.
            </div>
            <div>
              <strong class="text-slate-700">Dosing assumptions:</strong> Doses derived from monotherapy studies without rapamycin.
              PK interactions may shift optimal doses.
            </div>
          </div>
        </div>

        <!-- Legend -->
        <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-4">
          <h3 class="font-semibold text-slate-700 mb-3 text-sm">Notation Key</h3>
          <div class="grid grid-cols-2 md:grid-cols-5 gap-3 text-sm">
            <div class="flex items-center gap-2">
              <span class="font-mono bg-slate-100 px-2 py-0.5 rounded">C</span>
              <span class="text-slate-600">Vehicle control</span>
            </div>
            <div class="flex items-center gap-2">
              <span class="font-mono bg-slate-100 px-2 py-0.5 rounded">r</span>
              <span class="text-slate-600">Rapamycin only (benchmark)</span>
            </div>
            <div class="flex items-center gap-2">
              <span class="font-mono bg-slate-100 px-2 py-0.5 rounded">X</span>
              <span class="text-slate-600">Single intervention</span>
            </div>
            <div class="flex items-center gap-2">
              <span class="font-mono bg-slate-100 px-2 py-0.5 rounded">rX</span>
              <span class="text-slate-600">Intervention + rapamycin</span>
            </div>
            <div class="flex items-center gap-2">
              <span class="font-mono bg-slate-100 px-2 py-0.5 rounded">E</span>
              <span class="text-slate-600">All 8 interventions</span>
            </div>
          </div>
        </div>

      </div>

      <!-- Footer -->
      <div class="mt-8 pt-4 border-t border-slate-200">
        <div class="text-center text-xs text-slate-400">
          LEV Foundation | RMR2 Phased Study Design & Analysis Framework | February 2026
        </div>
      </div>
    </div>
  </div>

  <!-- ==================== FRAMEWORK TAB ==================== -->
  <div id="framework-tab" class="tab-content">
    <div class="max-w-6xl mx-auto p-6">
      <div class="flex gap-6">

        <!-- Navigation sidebar -->
        <div class="w-64 flex-shrink-0 hidden lg:block">
          <div class="framework-nav">
            <div class="text-xs text-slate-500 mb-3 uppercase tracking-wide">Contents</div>
            <a href="#fw-1" class="nav-section">1. Strategic Context</a>
            <a href="#fw-1-1">1.1 Program Overview</a>
            <a href="#fw-1-2">1.2 Rapamycin Benchmark</a>
            <a href="#fw-1-3">1.3 Mechanistic Uncertainty</a>
            <a href="#fw-1-4">1.4 The Damage Network</a>
            <a href="#fw-1-5">1.5 Intervention Selection</a>

            <a href="#fw-2" class="nav-section">2. Phase 1 Design</a>
            <a href="#fw-2-1">2.1 Group Structure</a>
            <a href="#fw-2-2">2.2 Design Rationale</a>

            <a href="#fw-3" class="nav-section">3. Analysis Framework</a>
            <a href="#fw-3-1">3.1 Individual Patterns (rX vs r)</a>
            <a href="#fw-3-2">3.2 Combination Patterns</a>
            <a href="#fw-3-3">3.3 Best Case Scenario</a>

            <a href="#fw-4" class="nav-section">4. Secondary Endpoints</a>

            <a href="#fw-5" class="nav-section">5. Phase 2 Logic</a>
            <a href="#fw-6" class="nav-section">6. Pairwise Interactions</a>
            <a href="#fw-7" class="nav-section">7. Design Limitations</a>
            <a href="#fw-8" class="nav-section">8. Key Comparisons</a>
            <a href="#fw-9" class="nav-section">9. Glossary</a>
            <a href="#fw-10" class="nav-section">10. Appendix</a>
          </div>
        </div>

        <!-- Main content -->
        <div class="flex-1 min-w-0">

          <!-- Section 1 -->
          <div id="fw-1" class="section">
            <h2>1. Strategic Context</h2>

            <h3 id="fw-1-1">1.1 Program Overview</h3>
            <p>RMR2 is a comprehensive longevity study testing the combined effects of eight interventions on mouse lifespan. The program follows a phased approach:</p>

            <table>
              <thead><tr><th>Phase</th><th>Purpose</th><th>Scale</th></tr></thead>
              <tbody>
                <tr><td><strong>Pilots</strong> (current)</td><td>Validation & de-risking</td><td>~200 mice total</td></tr>
                <tr><td><strong>Phase 1</strong></td><td>Monotherapy + full combination testing</td><td>1,200 mice</td></tr>
                <tr><td><strong>Phase 2</strong></td><td>Subtractive combination testing</td><td>~800 mice (variable)</td></tr>
                <tr><td><strong>Total</strong></td><td></td><td>~2,000 mice</td></tr>
              </tbody>
            </table>

            <p><strong>Target outcome:</strong> Double remaining lifespan from 18 months of age (~100% extension). Any statistically significant result where E > r (combination exceeds rapamycin) constitutes success.</p>

            <h3 id="fw-1-2">1.2 The Rapamycin Benchmark</h3>
            <p>Rapamycin (r) serves as the benchmark intervention for this study. It is the best-characterized lifespan-extending intervention in mice, typically producing ~25-30% lifespan extension with highly reproducible results across laboratories.</p>
            <p>However, mTOR-axis interventions have not translated effectively to humans. The goal of RMR2 is therefore twofold:</p>
            <ol class="list-decimal ml-6 my-3 space-y-1">
              <li><strong>Exceed the benchmark:</strong> Find an intervention combination (E) that significantly outperforms rapamycin</li>
              <li><strong>Independence from mTOR:</strong> Ideally achieve this without rapamycin contributing (E ‚âà rE), suggesting the combination works through distinct mechanisms with better human translation potential</li>
            </ol>

            <h3 id="fw-1-3">1.3 Operating Principle: Mechanistic Uncertainty</h3>
            <p><strong>We lack complete mechanistic understanding of how <em>any</em> intervention extends lifespan.</strong> Rather than assume biology, we use empirical inference from outcomes.</p>
            <p>This has important implications:</p>
            <ul class="list-disc ml-6 my-3 space-y-1">
              <li>We cannot assume that similar outcomes imply similar mechanisms</li>
              <li>We cannot assume that pathway knowledge from other contexts applies to lifespan extension</li>
              <li>We can only reason from observed effect patterns, not from assumed biology</li>
            </ul>
            <p><strong>Operational definition of "functional rapalog":</strong> An intervention that provides no additional benefit when combined with rapamycin (rX ‚âà r), suggesting it achieves the same outcome through overlapping or redundant means‚Äîregardless of whether we know the mechanism. This is testable without mechanistic knowledge.</p>

            <h3 id="fw-1-4">1.4 The Damage Network</h3>
            <p>Aging involves multiple damage types that are interconnected rather than independent. Damage type A may accelerate B; B may accelerate C; C may feed back to A. Interventions have primary targets, but effects propagate through this network via crosstalk and knock-on effects.</p>

            <p><strong>This has important implications:</strong></p>
            <ul class="list-disc ml-6 my-3 space-y-1">
              <li>An intervention addressing damage type A may extend lifespan even if A is not itself rate-limiting, provided A's downstream effects include rate-limiting damage types</li>
              <li>An intervention may appear to "overlap" with rapamycin not because they share a molecular target, but because their effects converge through network propagation</li>
              <li>The position of a damage type in the network (upstream hub vs. peripheral node) matters as much as whether it is rate-limiting</li>
              <li>Interventions affecting upstream hubs that cascade to multiple rate-limiters have higher potential value than those addressing peripheral nodes</li>
            </ul>

            <p>We cannot map the full mouse damage network, let alone the human one. But we can use empirical signals to infer network relationships and make probabilistic judgments about translation potential.</p>

            <p><strong>Network position terminology:</strong></p>
            <table>
              <thead><tr><th>Term</th><th>Definition</th></tr></thead>
              <tbody>
                <tr><td><strong>Upstream hub</strong></td><td>Damage type whose accumulation drives multiple downstream damage types; addressing it has broad effects</td></tr>
                <tr><td><strong>Downstream node</strong></td><td>Damage type driven by upstream processes; addressing it may have limited effect if upstream drivers continue</td></tr>
                <tr><td><strong>Peripheral node</strong></td><td>Damage type with limited connections; addressing it affects only itself unless it happens to be rate-limiting</td></tr>
                <tr><td><strong>Cascade</strong></td><td>The propagation of an intervention's effects through network connections (knock-on effects)</td></tr>
              </tbody>
            </table>

            <h3 id="fw-1-5">1.5 Intervention Selection</h3>
            <p>The eight interventions were selected to address largely different types of age-related damage, with known lifespan-extending effects in prior studies:</p>
            <table>
              <thead><tr><th>Intervention</th><th>Primary Target/Damage Type</th></tr></thead>
              <tbody>
                <tr><td>X‚ÇÅ: OSK</td><td>Epigenetic reprogramming</td></tr>
                <tr><td>X‚ÇÇ: d-PUFAs</td><td>Lipid peroxidation</td></tr>
                <tr><td>X‚ÇÉ: Oxytocin</td><td>Neuroendocrine / social signaling</td></tr>
                <tr><td>X‚ÇÑ: CASIN</td><td>Cellular polarity / stem cell aging</td></tr>
                <tr><td>X‚ÇÖ: Anti-IL-11</td><td>Inflammatory signaling</td></tr>
                <tr><td>X‚ÇÜ: Exosomes</td><td>Intercellular communication / regeneration</td></tr>
                <tr><td>X‚Çá: Senolytic</td><td>Senescent cell clearance</td></tr>
                <tr><td>X‚Çà: rMSA</td><td>Plasma proteome / albumin function</td></tr>
              </tbody>
            </table>
          </div>

          <!-- Section 2 -->
          <div id="fw-2" class="section">
            <h2>2. Phase 1 Study Design</h2>

            <h3 id="fw-2-1">2.1 Group Structure</h3>
            <p>Phase 1 tests all interventions as monotherapies (with and without rapamycin) plus the full combination.</p>

            <h4>Without Rapamycin:</h4>
            <table>
              <thead><tr><th>Group</th><th>Description</th><th>n per sex</th><th>Total</th></tr></thead>
              <tbody>
                <tr><td>C</td><td>Vehicle control</td><td>50</td><td>100</td></tr>
                <tr><td>X‚ÇÅ ‚Äì X‚Çà</td><td>Monotherapies (8 groups)</td><td>25</td><td>400</td></tr>
                <tr><td>E</td><td>All 8 interventions combined</td><td>50</td><td>100</td></tr>
              </tbody>
            </table>

            <h4>With Rapamycin:</h4>
            <table>
              <thead><tr><th>Group</th><th>Description</th><th>n per sex</th><th>Total</th></tr></thead>
              <tbody>
                <tr><td>r</td><td>Rapamycin only (benchmark)</td><td>50</td><td>100</td></tr>
                <tr><td>rX‚ÇÅ ‚Äì rX‚Çà</td><td>Monotherapy + rapamycin (8 groups)</td><td>25</td><td>400</td></tr>
                <tr><td>rE</td><td>All 8 + rapamycin</td><td>50</td><td>100</td></tr>
              </tbody>
            </table>
            <p><strong>Phase 1 Total:</strong> 20 groups, 1,200 mice</p>

            <h3 id="fw-2-2">2.2 Design Rationale</h3>
            <p>This design enables several key comparisons:</p>
            <h4>Individual intervention level:</h4>
            <ul class="list-disc ml-6 my-2">
              <li><span class="font-mono">X vs C</span> ‚Üí Does intervention have any independent effect?</li>
              <li><span class="font-mono">X vs r</span> ‚Üí How does intervention compare to benchmark?</li>
              <li><span class="font-mono bg-blue-100 px-1 rounded">rX vs r</span> ‚Üí Does intervention add to rapamycin's effect? <strong>(Key test)</strong></li>
              <li><span class="font-mono">rX vs X</span> ‚Üí Does rapamycin add to intervention's effect?</li>
            </ul>
            <h4>Combination level:</h4>
            <ul class="list-disc ml-6 my-2">
              <li><span class="font-mono bg-emerald-100 px-1 rounded">E vs r</span> ‚Üí Does combination beat rapamycin? <strong>(Primary success criterion)</strong></li>
              <li><span class="font-mono bg-purple-100 px-1 rounded">rE vs E</span> ‚Üí Does rapamycin add to combination? <strong>(Translation signal)</strong></li>
              <li><span class="font-mono">rE vs r</span> ‚Üí Does combination contribute beyond rapamycin?</li>
            </ul>
          </div>

          <!-- Section 3 -->
          <div id="fw-3" class="section">
            <h2>3. Analysis Framework</h2>

            <h3 id="fw-3-1">3.1 Interpreting Individual Patterns: rX vs r</h3>

            <h4>Scenario 1: rX > r (Synergy)</h4>
            <div class="callout callout-green">
              <p><strong>Observation:</strong> Intervention X adds benefit beyond rapamycin alone.</p>
              <p><strong>Interpretation:</strong> X likely acts through pathway independent of mTOR inhibition.</p>
              <p><strong>Implications:</strong> Promising for human translation (non-mTOR mechanism). Keep in combination.</p>
            </div>

            <h4>Scenario 2: rX ‚âà r (No Additional Benefit)</h4>
            <div class="callout callout-amber">
              <p><strong>Observation:</strong> Adding X to rapamycin provides no improvement over rapamycin alone.</p>
              <p><strong>Three competing explanations:</strong></p>
              <table class="mt-2">
                <thead><tr><th>Explanation</th><th>Description</th><th>Translation</th></tr></thead>
                <tbody>
                  <tr style="background:#fef2f2"><td><strong>1. Target overlap</strong></td><td>X works through same/similar pathway as rapamycin</td><td>Poor</td></tr>
                  <tr style="background:#f0fdf4"><td><strong>2. Damage-type masking</strong></td><td>X works independently, but addresses damage not rate-limiting after r</td><td>Good</td></tr>
                  <tr style="background:#ecf9ff"><td><strong>3. Network masking</strong></td><td>X's effects propagate through nodes that r has already addressed; X's cascade is "orphaned"</td><td>Good (humans lack r)</td></tr>
                </tbody>
              </table>
              <p class="mt-2"><strong>Critical limitation:</strong> Lifespan data alone cannot distinguish these explanations. All three produce rX ‚âà r. Secondary endpoints are required for diagnosis (see Section 4).</p>
            </div>

            <h4>Scenario 3: rX < r (Antagonism)</h4>
            <div class="callout callout-red">
              <p><strong>Observation:</strong> Adding X to rapamycin <em>reduces</em> the benefit.</p>
              <p><strong>Implications:</strong> Definitely test E-X and rE-X in Phase 2. X is likely dragging down combination performance.</p>
            </div>

            <h3 id="fw-3-2">3.2 Interpreting Combination Patterns</h3>

            <h4>E vs r (Primary Success Criterion)</h4>
            <table>
              <thead><tr><th>Outcome</th><th>Interpretation</th><th>Action</th></tr></thead>
              <tbody>
                <tr style="background:#f0fdf4"><td><strong>E >> r</strong></td><td>Primary goal achieved</td><td>Proceed to optimization</td></tr>
                <tr style="background:#fffbeb"><td><strong>E ‚âà r</strong></td><td>Combination matches but doesn't beat benchmark</td><td>Look for redundancy/antagonism</td></tr>
                <tr style="background:#fef2f2"><td><strong>E < r</strong></td><td>Combination underperforms</td><td>Investigate interactions</td></tr>
              </tbody>
            </table>

            <h4>rE vs E (Translation Signal)</h4>
            <table>
              <thead><tr><th>Outcome</th><th>Interpretation</th><th>Implication</th></tr></thead>
              <tbody>
                <tr><td><strong>rE >> E</strong></td><td>Rapamycin adds substantial value</td><td>Combination alone insufficient</td></tr>
                <tr style="background:#f0fdf4"><td><strong>rE ‚âà E</strong></td><td>Rapamycin adds nothing</td><td><strong>Ideal for translation</strong></td></tr>
                <tr style="background:#fef2f2"><td><strong>rE < E</strong></td><td>Rapamycin antagonizes combination</td><td>Investigate conflicts</td></tr>
              </tbody>
            </table>

            <h3 id="fw-3-3">3.3 Best Case Scenario</h3>
            <div class="callout callout-green">
              <p class="font-mono text-lg font-bold mb-2">E >> r AND E ‚â• rE</p>
              <ul class="list-disc ml-6">
                <li>‚úì Combination dramatically exceeds rapamycin benchmark</li>
                <li>‚úì Rapamycin doesn't add value to the combination</li>
                <li>‚úì Effects likely achieved through non-mTOR mechanisms</li>
                <li>‚úì Strong candidate for human translation</li>
              </ul>
            </div>
          </div>

          <!-- Section 4 -->
          <div id="fw-4" class="section">
            <h2>4. Secondary Endpoints & Tissue Banking</h2>

            <p>While lifespan is the primary endpoint, the study will collect extensive functional, clinical, and biological data throughout. These secondary endpoints serve multiple critical functions.</p>

            <h3>4.1 Endpoint Categories</h3>

            <p><strong>Functional Assessments</strong> (longitudinal, in-life)</p>
            <ul class="list-disc ml-6 my-2">
              <li>Grip strength</li>
              <li>Running wheel activity</li>
              <li>Cognitive function (e.g., Barnes maze)</li>
              <li>Motor coordination (e.g., rotarod)</li>
            </ul>

            <p><strong>Clinical Evaluation</strong> (longitudinal, in-life)</p>
            <ul class="list-disc ml-6 my-2">
              <li>Frailty index assessments</li>
              <li>Body weight tracking</li>
              <li>Complete blood count (CBC)</li>
              <li>Blood chemistries</li>
              <li>Glucose tolerance testing (potentially)</li>
            </ul>

            <p><strong>Tissue Banking</strong> (terminal and interim)</p>
            <ul class="list-disc ml-6 my-2">
              <li>Full necropsy at death</li>
              <li>Blood and nearly all tissues banked</li>
              <li>Available for targeted post-hoc analyses</li>
            </ul>

            <h3>4.2 Diagnostic Value for Distinguishing Three Explanations</h3>

            <p>When rX ‚âà r, secondary endpoints become <strong>diagnostic</strong> for determining whether X is a functional rapalog (concerning) or masked/network-masked (potentially fine for translation):</p>
            <table>
              <thead><tr><th>Lifespan Result</th><th>Secondary Endpoint Finding</th><th>Interpretation</th></tr></thead>
              <tbody>
                <tr><td>rX ‚âà r</td><td>X improves its target biomarkers in rX vs r</td><td><strong style="color:#059669">Masking/Network masking</strong> ‚Äî X is working; effects don't translate to lifespan because X addresses non-rate-limiting damage or r has blocked X's cascade</td></tr>
                <tr><td>rX ‚âà r</td><td>X shows no biomarker improvement in rX vs r</td><td>Possibly <strong style="color:#dc2626">Overlap</strong> ‚Äî X may not be working in r-treated context</td></tr>
                <tr><td>rX ‚âà r</td><td>X affects mTOR pathway markers</td><td><strong style="color:#dc2626">Target overlap</strong> ‚Äî X is a functional rapalog</td></tr>
                <tr><td>rX ‚âà r</td><td>X doesn't affect mTOR markers, improves different domains than r</td><td><strong style="color:#059669">Masking/Network masking</strong> ‚Äî different mechanisms, different damage targets</td></tr>
              </tbody>
            </table>
          </div>

          <!-- Section 5 -->
          <div id="fw-5" class="section">
            <h2>5. Phase 2 Decision Logic</h2>

            <h3>5.1 Phase 2 Design</h3>
            <p>Phase 2 tests subtractive combinations: the full combination minus individual interventions.</p>

            <table>
              <thead><tr><th>Group Type</th><th>Description</th></tr></thead>
              <tbody>
                <tr><td><span class="font-mono">E ‚Äì X·µ¢</span></td><td>Full combination minus intervention i</td></tr>
                <tr><td><span class="font-mono">rE ‚Äì X·µ¢</span></td><td>Full combination + rapamycin minus intervention i</td></tr>
              </tbody>
            </table>
            <p><strong>Estimated scale:</strong> ~800 additional mice (variable based on Phase 1 results)</p>

            <h3>5.2 Decision Framework</h3>
            <div class="decision-tree">Phase 1 Complete
‚îÇ
‚îú‚îÄ‚ñ∫ IF E > r (Primary goal achieved)
‚îÇ   ‚îÇ
‚îÇ   ‚îú‚îÄ‚ñ∫ IF E ‚âà rE (Rapamycin adds nothing)
‚îÇ   ‚îÇ   ‚îî‚îÄ‚ñ∫ Phase 2: Test E-X·µ¢ to find MINIMAL EFFECTIVE COMBINATION
‚îÇ   ‚îÇ       (Optimization for translation practicality)
‚îÇ   ‚îÇ
‚îÇ   ‚îî‚îÄ‚ñ∫ IF rE >> E (Rapamycin still adds value)
‚îÇ       ‚îî‚îÄ‚ñ∫ Phase 2: May test both E-X·µ¢ and rE-X·µ¢
‚îÇ           (Understand what rapamycin provides that combination doesn't)
‚îÇ
‚îú‚îÄ‚ñ∫ IF E ‚âà r (Combination matches but doesn't beat benchmark)
‚îÇ   ‚îî‚îÄ‚ñ∫ Phase 2: Test E-X·µ¢ to find REDUNDANCY or ANTAGONISM
‚îÇ       (Prioritize X·µ¢ where rX·µ¢ ‚â§ r)
‚îÇ
‚îî‚îÄ‚ñ∫ IF E < r (Combination underperforms)
    ‚îî‚îÄ‚ñ∫ Phase 2: Test E-X·µ¢ to find ANTAGONISTS
        (Prioritize X·µ¢ where rX·µ¢ < r, then rX·µ¢ ‚âà r)</div>

            <h3>5.3 Phase 2 Triggers by Scenario</h3>
            <table>
              <thead><tr><th>Phase 1 Outcome</th><th>Phase 2 Trigger</th><th>Purpose</th></tr></thead>
              <tbody>
                <tr><td>E >> r, E ‚âà rE</td><td>Test E-X·µ¢ for all i</td><td>Find minimal effective combination (optimization)</td></tr>
                <tr><td>E >> r, rE >> E</td><td>Test E-X·µ¢ and rE-X·µ¢</td><td>Understand rapamycin's contribution</td></tr>
                <tr><td>E ‚âà r</td><td>Test E-X·µ¢ starting with flagged interventions</td><td>Find what's dragging combination down</td></tr>
                <tr><td>E < r</td><td>Test E-X·µ¢ for rX ‚â§ r interventions first</td><td>Identify antagonists</td></tr>
                <tr><td>Specific pairs suspected</td><td>Consider X·µ¢ + X‚±º pair testing</td><td>Investigate pairwise interactions</td></tr>
              </tbody>
            </table>
          </div>

          <!-- Section 6 -->
          <div id="fw-6" class="section">
            <h2>6. Pairwise Interactions</h2>

            <h3>6.1 Limitation of Phase 1</h3>
            <p>Phase 1 cannot detect pairwise interactions between interventions (X·µ¢-X‚±º antagonism or synergy). Such interactions would only manifest through unexpected E or rE performance.</p>

            <h3>6.2 When to Consider Pairwise Testing</h3>

            <div class="callout callout-slate">
              <h4 class="font-semibold">Scenario A: E dramatically underperforms</h4>
              <ul class="list-disc ml-6 text-sm">
                <li>If E < r despite most rX > r, something is causing interference</li>
                <li>After E-X·µ¢ testing identifies candidate interventions, test specific pairs</li>
              </ul>
            </div>

            <div class="callout callout-slate">
              <h4 class="font-semibold">Scenario B: Two interventions show similar anomalous patterns</h4>
              <ul class="list-disc ml-6 text-sm">
                <li>If X‚ÇÅ and X‚ÇÇ both show rX ‚âà r, test X‚ÇÅ + X‚ÇÇ to determine if they're redundant with each other</li>
              </ul>
            </div>

            <h3>6.3 Incorporating Pair Testing</h3>

            <h4>Option 1: Contingent Phase 1.5</h4>
            <p>If Phase 1 raises specific questions, run a small focused study (~100-200 mice) testing 3-5 specific pairs before committing to full Phase 2.</p>

            <h4>Option 2: Expand Phase 2 scope</h4>
            <p>Include targeted pair tests (X·µ¢ + X‚±º) or double subtractions (E - X·µ¢ - X‚±º) alongside standard E-X·µ¢ testing.</p>

            <h4>Option 3: Statistical modeling</h4>
            <p>Use Phase 1 data to fit a model assuming additive effects. Large residuals (E observed vs. E predicted) indicate non-additive interactions, triggering investigation.</p>
          </div>

          <!-- Section 7 -->
          <div id="fw-7" class="section">
            <h2>7. Design Limitations & Considerations</h2>
            <ul class="list-disc ml-6 my-2">
              <li><strong>Higher-order interactions:</strong> Pairwise antagonism only visible through E underperformance</li>
              <li><strong>Statistical power:</strong> n=50 per monotherapy may miss small (5-10%) effects</li>
              <li><strong>Masking/Network effects:</strong> rX ‚âà r may reflect masking or network masking, not overlap (see Section 3)</li>
              <li><strong>Temporal considerations:</strong> Cannot detect timing-dependent effects</li>
            </ul>
          </div>

          <!-- Section 8 -->
          <div id="fw-8" class="section">
            <h2>8. Summary: Key Comparisons</h2>
            <table>
              <thead><tr><th>Comparison</th><th>What It Tests</th><th>Key Outcomes</th></tr></thead>
              <tbody>
                <tr><td><span class="font-mono">X vs C</span></td><td>Independent effect</td><td>X > C = intervention works</td></tr>
                <tr><td><span class="font-mono">X vs r</span></td><td>Intervention vs. benchmark</td><td>X ‚âà r = remarkable</td></tr>
                <tr style="background:#eff6ff"><td><span class="font-mono font-bold">rX vs r</span></td><td><strong>Functional rapalog test</strong></td><td>rX > r = independent; rX ‚âà r = possible rapalog (but may be masking/network masking); rX < r = antagonism</td></tr>
                <tr style="background:#f0fdf4"><td><span class="font-mono font-bold">E vs r</span></td><td><strong>Primary success</strong></td><td>E > r = goal achieved</td></tr>
                <tr style="background:#faf5ff"><td><span class="font-mono font-bold">rE vs E</span></td><td><strong>Translation signal</strong></td><td>rE ‚âà E = ideal</td></tr>
                <tr><td><span class="font-mono">E-X·µ¢ vs E</span></td><td>Contribution of X·µ¢</td><td>E-X·µ¢ ‚âà E = passenger; E-X·µ¢ < E = contributes; E-X·µ¢ > E = antagonist</td></tr>
              </tbody>
            </table>
          </div>

          <!-- Section 9 -->
          <div id="fw-9" class="section">
            <h2>9. Glossary of Notation</h2>
            <table>
              <thead><tr><th>Symbol</th><th>Meaning</th></tr></thead>
              <tbody>
                <tr><td><span class="font-mono bg-slate-100 px-2 py-0.5 rounded">C</span></td><td>Vehicle control (no intervention)</td></tr>
                <tr><td><span class="font-mono bg-amber-100 px-2 py-0.5 rounded">r</span></td><td>Rapamycin only (benchmark)</td></tr>
                <tr><td><span class="font-mono bg-blue-100 px-2 py-0.5 rounded">X</span></td><td>Any single intervention (X‚ÇÅ through X‚Çà)</td></tr>
                <tr><td><span class="font-mono bg-orange-100 px-2 py-0.5 rounded">rX</span></td><td>Intervention + rapamycin</td></tr>
                <tr><td><span class="font-mono bg-emerald-100 px-2 py-0.5 rounded">E</span></td><td>Full combination (all 8 interventions)</td></tr>
                <tr><td><span class="font-mono bg-rose-100 px-2 py-0.5 rounded">rE</span></td><td>Full combination + rapamycin</td></tr>
                <tr><td><span class="font-mono bg-purple-100 px-2 py-0.5 rounded">E-X·µ¢</span></td><td>Full combination minus intervention i</td></tr>
                <tr><td><span class="font-mono bg-purple-100 px-2 py-0.5 rounded">rE-X·µ¢</span></td><td>Full combination + rapamycin minus intervention i</td></tr>
              </tbody>
            </table>
          </div>

          <!-- Section 10 - Appendix -->
          <div id="fw-10" class="section">
            <h2>10. Appendix: Fundamental Translation Limitation</h2>

            <p><strong>What the rX test can and cannot tell us:</strong></p>

            <p>The rX ‚âà r test functions as a <strong>negative filter</strong>, not a positive confirmation. It identifies interventions that likely face rapamycin's translation barrier but cannot confirm that other interventions will translate.</p>

            <h3>The rX test CAN:</h3>
            <ul class="list-disc ml-6 my-2">
              <li>Identify interventions sharing rapamycin's molecular target (Category 1: Target overlap)</li>
              <li>Flag interventions whose effects are masked by rapamycin's action (Category 2/3: Masking or network masking)</li>
              <li>Reduce the hypothesis space by eliminating one class of likely failures</li>
            </ul>

            <h3>The rX test CANNOT:</h3>
            <ul class="list-disc ml-6 my-2">
              <li>Confirm that rX > r interventions will translate to humans</li>
              <li>Predict human damage landscapes</li>
              <li>Account for network topology differences between species</li>
              <li>Guarantee that "passing" interventions address human rate-limiting damage</li>
            </ul>

            <h3>Interventions showing rX > r may still fail in humans due to:</h3>
            <ul class="list-disc ml-6 my-2">
              <li>Damage landscape differences (X's target may not be rate-limiting in humans)</li>
              <li>Network position differences (upstream hub in mice might be peripheral in humans)</li>
              <li>Life history constraints (dosing, duration, age at intervention)</li>
              <li>Unknown human-specific barriers</li>
            </ul>

            <p><strong>Bottom line:</strong> All interventions face uncertainty regardless of rX signal. This framework improves prioritization but does not guarantee success. "Passing" the rX test is necessary but not sufficient for human translation.</p>

          </div>

          <!-- Footer -->
          <div class="mt-8 pt-4 border-t border-slate-200">
            <div class="text-center text-xs text-slate-400">
              LEV Foundation | RMR2 Phased Study Design & Analysis Framework | February 2026
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <!-- ==================== WHY X TAB ==================== -->
  <div id="whyx-tab" class="tab-content">
    <div class="max-w-6xl mx-auto p-6">

    <!-- Header -->
    <div class="mb-8 pb-6 border-b-2 border-slate-300">
      <h1 class="text-3xl font-bold text-slate-900 mb-2">Why X Might Not Add to r</h1>
      <p class="text-lg text-slate-600">A Systematic Framework for Interpreting rX ‚âà r</p>
      <p class="text-sm text-slate-500 mt-2 italic">
        When adding intervention X to rapamycin provides no additional benefit, what does it mean?
      </p>
    </div>

    <!-- The Setup -->
    <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6 mb-6">
      <h2 class="text-xl font-bold text-slate-800 mb-4">The Setup</h2>

      <div class="grid grid-cols-3 gap-4 mb-4">
        <div class="bg-blue-50 rounded-lg p-4 border border-blue-200 text-center">
          <div class="text-sm text-blue-600 font-medium">X vs C</div>
          <div class="text-2xl font-bold text-blue-800 mt-1">+10%</div>
          <div class="text-xs text-blue-600">X works</div>
        </div>
        <div class="bg-amber-50 rounded-lg p-4 border border-amber-200 text-center">
          <div class="text-sm text-amber-600 font-medium">r vs C</div>
          <div class="text-2xl font-bold text-amber-800 mt-1">+25%</div>
          <div class="text-xs text-amber-600">r works (larger effect)</div>
        </div>
        <div class="bg-slate-100 rounded-lg p-4 border border-slate-300 text-center">
          <div class="text-sm text-slate-600 font-medium">rX vs r</div>
          <div class="text-2xl font-bold text-slate-800 mt-1">‚âà 0%</div>
          <div class="text-xs text-slate-600">X doesn't add</div>
        </div>
      </div>

      <div class="bg-amber-50 border border-amber-200 rounded-lg p-4">
        <p class="text-amber-800">
          <strong>The puzzle:</strong> If X and r are mechanistically independent, we'd naively expect
          rX ‚âà +35% (additive). But we see rX ‚âà +25%. Why doesn't X add?
        </p>
      </div>
    </div>

    <!-- Category 1: Mechanistic -->
    <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6 mb-6">
      <div class="flex items-center gap-3 mb-4">
        <div class="w-10 h-10 bg-red-100 rounded-full flex items-center justify-center">
          <span class="text-red-600 font-bold">1</span>
        </div>
        <h2 class="text-xl font-bold text-slate-800">Category 1: Mechanistic Overlap</h2>
      </div>
      <p class="text-slate-600 mb-4">X and r share something mechanistically ‚Äî they're not truly independent.</p>

      <div class="space-y-4">
        <!-- 1A -->
        <div class="border-l-4 border-red-400 pl-4 py-2 bg-red-50 rounded-r-lg">
          <h4 class="font-semibold text-red-800">1A. Target-Level Redundancy</h4>
          <p class="text-sm text-slate-600 mb-2">
            X and r directly affect the same molecular target (e.g., both inhibit mTOR).
          </p>
          <div class="flex gap-4 text-xs">
            <div class="bg-white rounded p-2 border border-red-200">
              <span class="text-red-600 font-medium">Prediction:</span>
              <span class="text-slate-600">X's molecular signature overlaps with r's. mTOR markers similar in X, r, rX.</span>
            </div>
            <div class="bg-white rounded p-2 border border-red-200">
              <span class="text-red-600 font-medium">Translation:</span>
              <span class="text-slate-600">Bad ‚Äî X depends on mTOR, which doesn't translate.</span>
            </div>
          </div>
        </div>

        <!-- 1B -->
        <div class="border-l-4 border-orange-400 pl-4 py-2 bg-orange-50 rounded-r-lg">
          <h4 class="font-semibold text-orange-800">1B. Pathway-Level Convergence</h4>
          <p class="text-sm text-slate-600 mb-2">
            X affects a different target but the same pathway (e.g., X is upstream of mTOR).
          </p>
          <div class="flex gap-4 text-xs">
            <div class="bg-white rounded p-2 border border-orange-200">
              <span class="text-orange-600 font-medium">Prediction:</span>
              <span class="text-slate-600">X alone shows mTOR pathway changes. rX shows no additional suppression vs r.</span>
            </div>
            <div class="bg-white rounded p-2 border border-orange-200">
              <span class="text-orange-600 font-medium">Translation:</span>
              <span class="text-slate-600">Moderate concern ‚Äî mTOR-adjacent biology.</span>
            </div>
          </div>
        </div>

        <!-- 1C -->
        <div class="border-l-4 border-amber-400 pl-4 py-2 bg-amber-50 rounded-r-lg">
          <h4 class="font-semibold text-amber-800">1C. Downstream Convergence</h4>
          <p class="text-sm text-slate-600 mb-2">
            X works through a different upstream pathway but converges on the same downstream effect
            (e.g., both increase autophagy through different routes).
          </p>
          <div class="flex gap-4 text-xs">
            <div class="bg-white rounded p-2 border border-amber-200">
              <span class="text-amber-600 font-medium">Prediction:</span>
              <span class="text-slate-600">X and r affect same downstream readout. Different upstream markers.</span>
            </div>
            <div class="bg-white rounded p-2 border border-amber-200">
              <span class="text-amber-600 font-medium">Translation:</span>
              <span class="text-slate-600">Ambiguous ‚Äî doesn't depend on mTOR per se, but same output biology.</span>
            </div>
          </div>
        </div>
      </div>
    </div>

    <!-- Category 2: Structural (Masking) -->
    <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6 mb-6">
      <div class="flex items-center gap-3 mb-4">
        <div class="w-10 h-10 bg-emerald-100 rounded-full flex items-center justify-center">
          <span class="text-emerald-600 font-bold">2</span>
        </div>
        <h2 class="text-xl font-bold text-slate-800">Category 2: Structural Masking</h2>
      </div>
      <p class="text-slate-600 mb-4">
        X and r are truly independent, but X's effect is masked by the structure of how aging damage causes death.
      </p>

      <div class="space-y-4">
        <!-- 2A -->
        <div class="border-l-4 border-emerald-400 pl-4 py-3 bg-emerald-50 rounded-r-lg">
          <h4 class="font-semibold text-emerald-800">2A. Rate-Limiting Damage Shift</h4>
          <p class="text-sm text-slate-600 mb-3">
            Aging involves multiple damage types (A, B, C...) accumulating in parallel. Death occurs when
            the <em>first</em> damage type reaches a lethal threshold. r addresses the originally rate-limiting
            damage. Once that's fixed, a <em>different</em> damage type becomes rate-limiting ‚Äî and it's not
            the one X addresses.
          </p>

          <div class="bg-white rounded-lg p-4 border border-emerald-200 mb-3">
            <h5 class="font-medium text-emerald-700 mb-2">Example:</h5>
            <div class="text-sm text-slate-600 space-y-1 font-mono">
              <div>Untreated: B kills @ 850 (A would @ 900, C @ 920)</div>
              <div>r-treated: B delayed to 1000, <span class="text-red-600 font-semibold">C now kills @ 920</span></div>
              <div>rX-treated: B‚Üí1000, A‚Üí950, <span class="text-red-600 font-semibold">C still kills @ 920</span></div>
              <div class="pt-2 text-emerald-700">Result: rX ‚âà r (both limited by C)</div>
            </div>
          </div>

          <div class="bg-emerald-100 rounded p-3 text-sm">
            <p class="text-emerald-800">
              <strong>Key insight:</strong> X addresses damage A, but A was <em>never going to be the cause of death</em>
              in r-treated mice. r changed the mortality landscape.
            </p>
          </div>

          <div class="flex gap-4 text-xs mt-3">
            <div class="bg-white rounded p-2 border border-emerald-200">
              <span class="text-emerald-600 font-medium">Prediction:</span>
              <span class="text-slate-600">X improves A-biomarkers in rX vs r, even if lifespan same. Cause of death is C, not A.</span>
            </div>
            <div class="bg-white rounded p-2 border border-emerald-200">
              <span class="text-emerald-600 font-medium">Translation:</span>
              <span class="text-slate-600">Good ‚Äî X works independently, just masked here. May work in humans if A is rate-limiting there.</span>
            </div>
          </div>
        </div>

        <!-- 2B -->
        <div class="border-l-4 border-teal-400 pl-4 py-2 bg-teal-50 rounded-r-lg">
          <h4 class="font-semibold text-teal-800">2B. Temporal Bottleneck Sequence</h4>
          <p class="text-sm text-slate-600 mb-2">
            Similar to 2A, but emphasizing temporal ordering. r removes an early bottleneck, but the
            <em>next</em> bottleneck in sequence isn't the one X addresses.
          </p>

          <div class="bg-white rounded-lg p-3 border border-teal-200 text-xs font-mono mb-2">
            <div class="text-slate-500">Untreated:</div>
            <div class="ml-2">[Birth]‚îÄ‚îÄ[<span class="text-red-600">B kills</span>]‚îÄ‚îÄ‚îÄ‚îÄ[A would]‚îÄ‚îÄ‚îÄ‚îÄ[C would]</div>
            <div class="text-slate-500 mt-1">r-treated:</div>
            <div class="ml-2">[Birth]‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ[<span class="text-red-600">C kills</span>]‚îÄ‚îÄ[A would]‚îÄ‚îÄ[B would]</div>
            <div class="text-slate-500 mt-1">rX-treated:</div>
            <div class="ml-2">[Birth]‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ[<span class="text-red-600">C kills</span>]‚îÄ‚îÄ[B would]‚îÄ‚îÄ[A delayed]</div>
          </div>

          <div class="text-xs">
            <span class="text-teal-600 font-medium">Translation:</span>
            <span class="text-slate-600">Good ‚Äî X works independently, just not next in sequence.</span>
          </div>
        </div>

        <!-- 2C -->
        <div class="border-l-4 border-cyan-400 pl-4 py-2 bg-cyan-50 rounded-r-lg">
          <h4 class="font-semibold text-cyan-800">2C. Damage Hierarchy with Dependencies</h4>
          <p class="text-sm text-slate-600 mb-2">
            Some damage types may be prerequisites for others. You can't die from A until B has progressed
            past a certain point. r slows B, which delays A as a downstream consequence. X also slows A,
            but A was already being slowed by r's effect on B.
          </p>
          <div class="text-xs">
            <span class="text-cyan-600 font-medium">Translation:</span>
            <span class="text-slate-600">Moderate ‚Äî X works independently, but effect contingent on damage hierarchy (may differ between species).</span>
          </div>
        </div>
      </div>
    </div>

    <!-- Category 3: Quantitative -->
    <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6 mb-6">
      <div class="flex items-center gap-3 mb-4">
        <div class="w-10 h-10 bg-blue-100 rounded-full flex items-center justify-center">
          <span class="text-blue-600 font-bold">3</span>
        </div>
        <h2 class="text-xl font-bold text-slate-800">Category 3: Quantitative Effects</h2>
      </div>
      <p class="text-slate-600 mb-4">Effect size issues that make X's contribution undetectable or compressed.</p>

      <div class="space-y-4">
        <!-- 3A -->
        <div class="border-l-4 border-blue-400 pl-4 py-2 bg-blue-50 rounded-r-lg">
          <h4 class="font-semibold text-blue-800">3A. Detection Threshold / Statistical Power</h4>
          <p class="text-sm text-slate-600 mb-2">
            X adds a real but small effect that we can't detect statistically. True rX = +30%, but with
            n=25, we observe rX ‚âà r because we can't distinguish 30% from 25%.
          </p>
          <div class="flex gap-4 text-xs">
            <div class="bg-white rounded p-2 border border-blue-200">
              <span class="text-blue-600 font-medium">Prediction:</span>
              <span class="text-slate-600">Larger sample sizes would reveal rX > r.</span>
            </div>
            <div class="bg-white rounded p-2 border border-blue-200">
              <span class="text-blue-600 font-medium">Translation:</span>
              <span class="text-slate-600">Neutral ‚Äî X works, we just can't measure it well.</span>
            </div>
          </div>
        </div>

        <!-- 3B -->
        <div class="border-l-4 border-indigo-400 pl-4 py-2 bg-indigo-50 rounded-r-lg">
          <h4 class="font-semibold text-indigo-800">3B. Diminishing Returns / Compressed Tail</h4>
          <p class="text-sm text-slate-600 mb-2">
            Each additional percentage of lifespan extension beyond a certain point is biologically "harder"
            to achieve. r captures the accessible gains. X's potential +10% is compressed to +3% in this regime.
          </p>
          <div class="flex gap-4 text-xs">
            <div class="bg-white rounded p-2 border border-indigo-200">
              <span class="text-indigo-600 font-medium">Prediction:</span>
              <span class="text-slate-600">Decreasing marginal returns when stacking any interventions. Pattern applies generally.</span>
            </div>
            <div class="bg-white rounded p-2 border border-indigo-200">
              <span class="text-indigo-600 font-medium">Translation:</span>
              <span class="text-slate-600">Moderate ‚Äî compression might apply in humans too, or might not.</span>
            </div>
          </div>
        </div>
      </div>
    </div>

    <!-- Category 4: Interaction -->
    <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6 mb-6">
      <div class="flex items-center gap-3 mb-4">
        <div class="w-10 h-10 bg-purple-100 rounded-full flex items-center justify-center">
          <span class="text-purple-600 font-bold">4</span>
        </div>
        <h2 class="text-xl font-bold text-slate-800">Category 4: Biological Interactions</h2>
      </div>
      <p class="text-slate-600 mb-4">Neither overlap nor pure masking ‚Äî real biological interactions between independent interventions.</p>

      <div class="space-y-4">
        <!-- 4A -->
        <div class="border-l-4 border-purple-400 pl-4 py-2 bg-purple-50 rounded-r-lg">
          <h4 class="font-semibold text-purple-800">4A. Combined Physiological Burden</h4>
          <p class="text-sm text-slate-600 mb-2">
            r imposes costs (immune suppression, metabolic changes). X also imposes costs. When combined,
            costs may sum while benefits don't fully add.
          </p>
          <div class="bg-white rounded p-2 text-xs font-mono border border-purple-200 mb-2">
            Benefits of rX: min(r_benefit + X_benefit, some_limit)<br>
            Costs of rX: r_cost + X_cost (fully additive)<br>
            Net: costs offset X's benefit ‚Üí rX ‚âà r
          </div>
          <div class="flex gap-4 text-xs">
            <div class="bg-white rounded p-2 border border-purple-200">
              <span class="text-purple-600 font-medium">Prediction:</span>
              <span class="text-slate-600">Safety signals in rX not seen in r or X alone.</span>
            </div>
            <div class="bg-white rounded p-2 border border-purple-200">
              <span class="text-purple-600 font-medium">Translation:</span>
              <span class="text-slate-600">Moderate ‚Äî combination burden is real and applies to humans.</span>
            </div>
          </div>
        </div>

        <!-- 4B -->
        <div class="border-l-4 border-fuchsia-400 pl-4 py-2 bg-fuchsia-50 rounded-r-lg">
          <h4 class="font-semibold text-fuchsia-800">4B. Indirect Damage Acceleration</h4>
          <p class="text-sm text-slate-600 mb-2">
            r's effect on damage B might indirectly accelerate damage C (e.g., immune suppression accelerates
            infection-related damage). C becomes rate-limiting, and X doesn't address C.
          </p>
          <div class="flex gap-4 text-xs">
            <div class="bg-white rounded p-2 border border-fuchsia-200">
              <span class="text-fuchsia-600 font-medium">Prediction:</span>
              <span class="text-slate-600">r-treated mice show elevated C-type damage markers vs untreated.</span>
            </div>
            <div class="bg-white rounded p-2 border border-fuchsia-200">
              <span class="text-fuchsia-600 font-medium">Translation:</span>
              <span class="text-slate-600">Context-dependent ‚Äî crosstalk may or may not exist in humans.</span>
            </div>
          </div>
        </div>

        <!-- 4C -->
        <div class="border-l-4 border-pink-400 pl-4 py-2 bg-pink-50 rounded-r-lg">
          <h4 class="font-semibold text-pink-800">4C. Resource Competition</h4>
          <p class="text-sm text-slate-600 mb-2">
            The organism has limited "repair capacity." r consumes most of this capacity addressing damage B.
            Not enough capacity left for X to effectively address A.
          </p>
          <div class="flex gap-4 text-xs">
            <div class="bg-white rounded p-2 border border-pink-200">
              <span class="text-pink-600 font-medium">Prediction:</span>
              <span class="text-slate-600">Repair/regeneration markers depleted in r-treated mice.</span>
            </div>
            <div class="bg-white rounded p-2 border border-pink-200">
              <span class="text-pink-600 font-medium">Translation:</span>
              <span class="text-slate-600">Moderate ‚Äî resource competition likely exists across species.</span>
            </div>
          </div>
        </div>
      </div>
    </div>

    <!-- Summary Table -->
    <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6 mb-6">
      <h2 class="text-xl font-bold text-slate-800 mb-4">Summary: All Explanations</h2>

      <div class="overflow-x-auto">
        <table class="text-sm">
          <thead>
            <tr>
              <th class="text-left">Explanation</th>
              <th class="text-center">X independent?</th>
              <th class="text-left">Why rX ‚âà r?</th>
              <th class="text-center">Translation</th>
            </tr>
          </thead>
          <tbody>
            <tr class="bg-red-50">
              <td class="font-medium">1A. Target redundancy</td>
              <td class="text-center text-red-600">No</td>
              <td>Same target</td>
              <td class="text-center"><span class="px-2 py-1 bg-red-100 text-red-700 rounded text-xs">Bad</span></td>
            </tr>
            <tr class="bg-orange-50">
              <td class="font-medium">1B. Pathway convergence</td>
              <td class="text-center text-orange-600">No</td>
              <td>Same pathway</td>
              <td class="text-center"><span class="px-2 py-1 bg-orange-100 text-orange-700 rounded text-xs">Moderate</span></td>
            </tr>
            <tr class="bg-amber-50">
              <td class="font-medium">1C. Downstream convergence</td>
              <td class="text-center text-amber-600">Partial</td>
              <td>Same output</td>
              <td class="text-center"><span class="px-2 py-1 bg-amber-100 text-amber-700 rounded text-xs">Ambiguous</span></td>
            </tr>
            <tr class="bg-emerald-50">
              <td class="font-medium">2A. Rate-limiting shift</td>
              <td class="text-center text-emerald-600">Yes</td>
              <td>A not rate-limiting after r</td>
              <td class="text-center"><span class="px-2 py-1 bg-emerald-100 text-emerald-700 rounded text-xs">Good</span></td>
            </tr>
            <tr class="bg-teal-50">
              <td class="font-medium">2B. Temporal bottleneck</td>
              <td class="text-center text-teal-600">Yes</td>
              <td>A not next in sequence</td>
              <td class="text-center"><span class="px-2 py-1 bg-emerald-100 text-emerald-700 rounded text-xs">Good</span></td>
            </tr>
            <tr class="bg-cyan-50">
              <td class="font-medium">2C. Damage hierarchy</td>
              <td class="text-center text-cyan-600">Yes</td>
              <td>A depends on B progression</td>
              <td class="text-center"><span class="px-2 py-1 bg-amber-100 text-amber-700 rounded text-xs">Moderate</span></td>
            </tr>
            <tr class="bg-blue-50">
              <td class="font-medium">3A. Detection threshold</td>
              <td class="text-center text-blue-600">Yes</td>
              <td>Can't measure small effect</td>
              <td class="text-center"><span class="px-2 py-1 bg-slate-100 text-slate-700 rounded text-xs">Neutral</span></td>
            </tr>
            <tr class="bg-indigo-50">
              <td class="font-medium">3B. Diminishing returns</td>
              <td class="text-center text-indigo-600">Yes</td>
              <td>Gains compressed at tail</td>
              <td class="text-center"><span class="px-2 py-1 bg-amber-100 text-amber-700 rounded text-xs">Moderate</span></td>
            </tr>
            <tr class="bg-purple-50">
              <td class="font-medium">4A. Combined burden</td>
              <td class="text-center text-purple-600">Yes</td>
              <td>Costs offset X benefit</td>
              <td class="text-center"><span class="px-2 py-1 bg-amber-100 text-amber-700 rounded text-xs">Moderate</span></td>
            </tr>
            <tr class="bg-fuchsia-50">
              <td class="font-medium">4B. Indirect acceleration</td>
              <td class="text-center text-fuchsia-600">Yes</td>
              <td>r accelerates C, C now limits</td>
              <td class="text-center"><span class="px-2 py-1 bg-slate-100 text-slate-700 rounded text-xs">Context</span></td>
            </tr>
            <tr class="bg-pink-50">
              <td class="font-medium">4C. Resource competition</td>
              <td class="text-center text-pink-600">Yes</td>
              <td>Repair capacity depleted</td>
              <td class="text-center"><span class="px-2 py-1 bg-amber-100 text-amber-700 rounded text-xs">Moderate</span></td>
            </tr>
          </tbody>
        </table>
      </div>
    </div>

    <!-- Visual: Rate-Limiting Damage -->
    <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6 mb-6">
      <h2 class="text-xl font-bold text-slate-800 mb-4">Visualizing Rate-Limiting Damage Shift</h2>

      <p class="text-sm text-slate-600 mb-4">
        Aging involves multiple damage types (A, B, C) accumulating toward lethal thresholds.
        Death occurs when the first damage type crosses its threshold. Different interventions
        address different damage types.
      </p>

      <div class="grid grid-cols-2 gap-4 mb-4">
        <!-- Untreated -->
        <div class="bg-slate-50 rounded-lg p-4 border border-slate-200">
          <h4 class="font-semibold text-slate-700 mb-3 text-center">C: Untreated (Control)</h4>
          <svg viewBox="0 0 220 150" class="w-full">
            <!-- Damage bars -->
            <text x="10" y="25" class="text-xs fill-slate-500">Damage A</text>
            <rect x="70" y="15" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="15" width="65" height="16" fill="#3b82f6" rx="2"/>

            <text x="10" y="55" class="text-xs fill-slate-500">Damage B</text>
            <rect x="70" y="45" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="45" width="95" height="16" fill="#f59e0b" rx="2"/>
            <text x="172" y="57" class="text-xs fill-red-500">‚òÖ</text>

            <text x="10" y="85" class="text-xs fill-slate-500">Damage C</text>
            <rect x="70" y="75" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="75" width="55" height="16" fill="#8b5cf6" rx="2"/>

            <!-- Threshold line -->
            <line x1="165" y1="10" x2="165" y2="100" stroke="#dc2626" stroke-width="2" stroke-dasharray="4,2"/>
            <text x="168" y="108" class="text-xs fill-red-500">lethal</text>

            <!-- Result -->
            <text x="115" y="130" text-anchor="middle" class="text-sm font-bold fill-amber-600">B kills first</text>
            <text x="115" y="145" text-anchor="middle" class="text-xs fill-slate-500">Death @ 850 days (baseline)</text>
          </svg>
        </div>

        <!-- X-treated -->
        <div class="bg-blue-50 rounded-lg p-4 border border-blue-200">
          <h4 class="font-semibold text-blue-700 mb-3 text-center">X: X-treated</h4>
          <svg viewBox="0 0 220 150" class="w-full">
            <!-- Damage bars -->
            <text x="10" y="25" class="text-xs fill-slate-500">Damage A</text>
            <rect x="70" y="15" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="15" width="40" height="16" fill="#3b82f6" rx="2"/>
            <text x="112" y="27" class="text-xs fill-blue-600 font-medium">‚Üì X</text>

            <text x="10" y="55" class="text-xs fill-slate-500">Damage B</text>
            <rect x="70" y="45" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="45" width="95" height="16" fill="#f59e0b" rx="2"/>
            <text x="172" y="57" class="text-xs fill-red-500">‚òÖ</text>

            <text x="10" y="85" class="text-xs fill-slate-500">Damage C</text>
            <rect x="70" y="75" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="75" width="60" height="16" fill="#8b5cf6" rx="2"/>

            <!-- Threshold line -->
            <line x1="165" y1="10" x2="165" y2="100" stroke="#dc2626" stroke-width="2" stroke-dasharray="4,2"/>
            <text x="168" y="108" class="text-xs fill-red-500">lethal</text>

            <!-- Result -->
            <text x="115" y="130" text-anchor="middle" class="text-sm font-bold fill-amber-600">B still kills</text>
            <text x="115" y="145" text-anchor="middle" class="text-xs fill-blue-600">Death @ 935 days (+10%)</text>
          </svg>
          <p class="text-xs text-blue-700 mt-2 text-center">X reduces A, providing resilience. B still dominates, but mice live longer.</p>
        </div>

        <!-- r-treated -->
        <div class="bg-amber-50 rounded-lg p-4 border border-amber-200">
          <h4 class="font-semibold text-amber-700 mb-3 text-center">r: r-treated (Rapamycin)</h4>
          <svg viewBox="0 0 220 150" class="w-full">
            <!-- Damage bars -->
            <text x="10" y="25" class="text-xs fill-slate-500">Damage A</text>
            <rect x="70" y="15" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="15" width="70" height="16" fill="#3b82f6" rx="2"/>

            <text x="10" y="55" class="text-xs fill-slate-500">Damage B</text>
            <rect x="70" y="45" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="45" width="45" height="16" fill="#f59e0b" rx="2"/>
            <text x="117" y="57" class="text-xs fill-amber-600 font-medium">‚Üì r</text>

            <text x="10" y="85" class="text-xs fill-slate-500">Damage C</text>
            <rect x="70" y="75" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="75" width="92" height="16" fill="#8b5cf6" rx="2"/>
            <text x="172" y="87" class="text-xs fill-red-500">‚òÖ</text>

            <!-- Threshold line -->
            <line x1="165" y1="10" x2="165" y2="100" stroke="#dc2626" stroke-width="2" stroke-dasharray="4,2"/>
            <text x="168" y="108" class="text-xs fill-red-500">lethal</text>

            <!-- Result -->
            <text x="115" y="130" text-anchor="middle" class="text-sm font-bold fill-purple-600">C now kills</text>
            <text x="115" y="145" text-anchor="middle" class="text-xs fill-amber-600">Death @ 1060 days (+25%)</text>
          </svg>
          <p class="text-xs text-amber-700 mt-2 text-center">r dramatically reduces B. C becomes rate-limiting.</p>
        </div>

        <!-- rX-treated -->
        <div class="bg-emerald-50 rounded-lg p-4 border border-emerald-200">
          <h4 class="font-semibold text-emerald-700 mb-3 text-center">rX: r + X treated</h4>
          <svg viewBox="0 0 220 150" class="w-full">
            <!-- Damage bars -->
            <text x="10" y="25" class="text-xs fill-slate-500">Damage A</text>
            <rect x="70" y="15" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="15" width="40" height="16" fill="#3b82f6" rx="2"/>
            <text x="112" y="27" class="text-xs fill-blue-600 font-medium">‚Üì X</text>

            <text x="10" y="55" class="text-xs fill-slate-500">Damage B</text>
            <rect x="70" y="45" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="45" width="45" height="16" fill="#f59e0b" rx="2"/>
            <text x="117" y="57" class="text-xs fill-amber-600 font-medium">‚Üì r</text>

            <text x="10" y="85" class="text-xs fill-slate-500">Damage C</text>
            <rect x="70" y="75" width="100" height="16" fill="#e2e8f0" rx="2"/>
            <rect x="70" y="75" width="92" height="16" fill="#8b5cf6" rx="2"/>
            <text x="172" y="87" class="text-xs fill-red-500">‚òÖ</text>

            <!-- Threshold line -->
            <line x1="165" y1="10" x2="165" y2="100" stroke="#dc2626" stroke-width="2" stroke-dasharray="4,2"/>
            <text x="168" y="108" class="text-xs fill-red-500">lethal</text>

            <!-- Result -->
            <text x="115" y="130" text-anchor="middle" class="text-sm font-bold fill-purple-600">C still kills</text>
            <text x="115" y="145" text-anchor="middle" class="text-xs fill-slate-600">Death @ 1060 days (= r alone)</text>
          </svg>
          <p class="text-xs text-emerald-700 mt-2 text-center">X reduces A, but A was never going to kill. C still rate-limiting.</p>
        </div>
      </div>

      <!-- Summary box -->
      <div class="bg-white rounded-lg border-2 border-slate-300 p-4 mb-4">
        <h4 class="font-semibold text-slate-800 mb-2">Summary of Outcomes:</h4>
        <div class="grid grid-cols-4 gap-2 text-sm text-center">
          <div class="bg-slate-100 rounded p-2">
            <div class="font-medium text-slate-700">C (Control)</div>
            <div class="text-slate-600">850 days</div>
            <div class="text-xs text-slate-500">baseline</div>
          </div>
          <div class="bg-blue-100 rounded p-2">
            <div class="font-medium text-blue-700">X</div>
            <div class="text-blue-600">935 days</div>
            <div class="text-xs text-blue-500">+10% ‚úì</div>
          </div>
          <div class="bg-amber-100 rounded p-2">
            <div class="font-medium text-amber-700">r</div>
            <div class="text-amber-600">1060 days</div>
            <div class="text-xs text-amber-500">+25% ‚úì</div>
          </div>
          <div class="bg-slate-100 rounded p-2 border-2 border-red-300">
            <div class="font-medium text-slate-700">rX</div>
            <div class="text-slate-600">1060 days</div>
            <div class="text-xs text-red-500">= r (no add)</div>
          </div>
        </div>
      </div>

      <div class="p-4 bg-emerald-100 rounded-lg border border-emerald-200">
        <p class="text-sm text-emerald-800 mb-2">
          <strong>Key insight:</strong> X works alone (+10%) because reducing Damage A provides resilience
          even when B is rate-limiting. But once r removes B from the picture, Damage C becomes rate-limiting ‚Äî
          and X doesn't address C.
        </p>
        <p class="text-sm text-emerald-800">
          X successfully reduces Damage A in rX (blue bar is shorter). But it doesn't extend lifespan because
          A was never going to be the cause of death in r-treated mice. This is <strong>masking</strong>, not overlap.
          X works through a completely independent mechanism ‚Äî it's just addressing the "wrong" damage type in this context.
        </p>
      </div>
    </div>

    <!-- Empirical Tests -->
    <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6 mb-6">
      <h2 class="text-xl font-bold text-slate-800 mb-4">Empirical Tests to Distinguish Categories</h2>

      <div class="space-y-4">
        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-blue-100 rounded-full flex items-center justify-center text-blue-600 font-bold text-sm">1</div>
          <div>
            <h4 class="font-semibold text-slate-800">Biomarker Analysis</h4>
            <p class="text-sm text-slate-600">
              If X addresses damage type A, does rX show improved A-markers vs r, even if lifespan doesn't differ?
            </p>
            <div class="mt-1 text-xs">
              <span class="text-emerald-600">Yes ‚Üí Masking (2A/2B)</span> ¬∑
              <span class="text-red-600">No ‚Üí Possibly overlap (1A/1B/1C)</span>
            </div>
          </div>
        </div>

        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-blue-100 rounded-full flex items-center justify-center text-blue-600 font-bold text-sm">2</div>
          <div>
            <h4 class="font-semibold text-slate-800">Cross-Intervention Pattern</h4>
            <p class="text-sm text-slate-600">
              Do most/all rX ‚âà r? Or only specific interventions?
            </p>
            <div class="mt-1 text-xs">
              <span class="text-indigo-600">Most/all rX ‚âà r ‚Üí Diminishing returns (3B)</span> ¬∑
              <span class="text-red-600">Only specific rX ‚âà r ‚Üí Those X's overlap or are specifically masked</span>
            </div>
          </div>
        </div>

        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-blue-100 rounded-full flex items-center justify-center text-blue-600 font-bold text-sm">3</div>
          <div>
            <h4 class="font-semibold text-slate-800">Cause-of-Death Analysis</h4>
            <p class="text-sm text-slate-600">
              What do r-treated mice actually die from? Histopathology and necropsy data.
            </p>
            <div class="mt-1 text-xs">
              <span class="text-emerald-600">Die from damage C (not A or B) ‚Üí Supports masking</span>
            </div>
          </div>
        </div>

        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-blue-100 rounded-full flex items-center justify-center text-blue-600 font-bold text-sm">4</div>
          <div>
            <h4 class="font-semibold text-slate-800">Pathway Markers</h4>
            <p class="text-sm text-slate-600">
              Does X affect mTOR signaling (p-S6K1, p-4EBP1)?
            </p>
            <div class="mt-1 text-xs">
              <span class="text-red-600">Yes ‚Üí Overlap (1A/1B)</span> ¬∑
              <span class="text-emerald-600">No ‚Üí X is mechanistically independent (Categories 2-4)</span>
            </div>
          </div>
        </div>

        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-blue-100 rounded-full flex items-center justify-center text-blue-600 font-bold text-sm">5</div>
          <div>
            <h4 class="font-semibold text-slate-800">Safety/Burden Analysis</h4>
            <p class="text-sm text-slate-600">
              Do safety signals appear in rX that don't appear in r or X alone?
            </p>
            <div class="mt-1 text-xs">
              <span class="text-purple-600">Yes ‚Üí Combined burden (4A)</span> ¬∑
              <span class="text-slate-600">No ‚Üí Not a burden explanation</span>
            </div>
          </div>
        </div>
      </div>
    </div>

    <!-- Mapping to the Three-Explanation Framework -->
    <div class="bg-slate-100 rounded-xl border border-slate-300 p-6 mb-6">
      <h2 class="text-xl font-bold text-slate-800 mb-4">Mapping to the RMR2 Three-Explanation Framework</h2>
      <p class="text-sm text-slate-700 mb-4">
        The RMR2 study framework uses three primary explanations for rX ‚âà r, organized around
        the question that matters most: <strong>does X work through biology independent of rapamycin?</strong>
        The detailed categories above map onto this framework as follows:
      </p>

      <div class="grid grid-cols-3 gap-4 mb-4">
        <div class="bg-white rounded-lg p-4 border border-red-200">
          <h4 class="font-semibold text-red-700 mb-2 text-sm">1. Target Overlap</h4>
          <p class="text-xs text-slate-600 mb-2">X works through the same or converging pathways as rapamycin.</p>
          <div class="text-xs text-slate-500 border-t border-slate-200 pt-2">
            <strong>Corresponds to:</strong> Category 1 (1A‚Äì1C)
          </div>
          <div class="mt-2 text-xs text-red-600 font-medium">Translation: Poor</div>
        </div>
        <div class="bg-white rounded-lg p-4 border border-emerald-200">
          <h4 class="font-semibold text-emerald-700 mb-2 text-sm">2. Damage-Type Masking</h4>
          <p class="text-xs text-slate-600 mb-2">X works independently but addresses damage that isn't rate-limiting after r.</p>
          <div class="text-xs text-slate-500 border-t border-slate-200 pt-2">
            <strong>Corresponds to:</strong> Category 2 (2A‚Äì2C)
          </div>
          <div class="mt-2 text-xs text-emerald-600 font-medium">Translation: Good</div>
        </div>
        <div class="bg-white rounded-lg p-4 border border-purple-200">
          <h4 class="font-semibold text-purple-700 mb-2 text-sm">3. Network Masking</h4>
          <p class="text-xs text-slate-600 mb-2">X's effects propagate through damage network nodes that r has already addressed.</p>
          <div class="text-xs text-slate-500 border-t border-slate-200 pt-2">
            <strong>Corresponds to:</strong> Category 4 (especially 4B, 4C) ‚Äî r reshapes the damage network, blocking X's downstream propagation
          </div>
          <div class="mt-2 text-xs text-purple-600 font-medium">Translation: Good (humans lack r context)</div>
        </div>
      </div>

      <div class="bg-white rounded-lg p-3 border border-slate-200">
        <p class="text-xs text-slate-600">
          <strong>Category 3</strong> (quantitative effects: detection threshold, diminishing returns) and
          <strong>Category 4A</strong> (combined physiological burden) represent additional considerations
          that can apply alongside any of the three primary explanations. They are study design and
          pharmacological factors rather than fundamental biological explanations for why X doesn't add to r.
        </p>
      </div>
    </div>

    <!-- Translation Implications -->
    <div class="bg-gradient-to-r from-emerald-50 to-blue-50 rounded-xl border border-slate-200 p-6 mb-6">
      <h2 class="text-xl font-bold text-slate-800 mb-4">Why This Matters for Human Translation</h2>

      <div class="grid grid-cols-2 gap-6">
        <div class="bg-white rounded-lg p-4 border border-red-200">
          <h4 class="font-semibold text-red-700 mb-2">If rX ‚âà r due to Overlap (Category 1)</h4>
          <p class="text-sm text-slate-600 mb-2">
            X works through mTOR or converging pathways. X is a "functional rapalog."
          </p>
          <div class="bg-red-50 rounded p-2 text-sm text-red-700">
            <strong>Translation:</strong> Probably won't work in humans. mTOR interventions don't translate well.
          </div>
        </div>

        <div class="bg-white rounded-lg p-4 border border-emerald-200">
          <h4 class="font-semibold text-emerald-700 mb-2">If rX ‚âà r due to Masking (Category 2)</h4>
          <p class="text-sm text-slate-600 mb-2">
            X works through an independent mechanism. X addresses damage that isn't rate-limiting in r-treated mice.
          </p>
          <div class="bg-emerald-50 rounded p-2 text-sm text-emerald-700">
            <strong>Translation:</strong> Might still work in humans because:
            <ul class="list-disc list-inside mt-1 text-xs">
              <li>Damage hierarchy may differ in humans</li>
              <li>The damage X addresses might be rate-limiting in humans</li>
              <li>Humans won't be on rapamycin (masking context doesn't apply)</li>
            </ul>
          </div>
        </div>
      </div>
    </div>

    <!-- Key Takeaway -->
    <div class="bg-slate-800 rounded-xl p-6 mb-6 text-white">
      <h2 class="text-xl font-bold mb-4">Key Takeaway for RMR2</h2>
      <p class="text-slate-200 mb-4">
        The framework's concern about "functional rapalogs" is really about <strong>Category 1</strong> ‚Äî
        interventions that work through mTOR or converging pathways and therefore won't translate to humans.
      </p>
      <p class="text-slate-200 mb-4">
        But if rX ‚âà r due to <strong>Category 2 (masking)</strong>, the intervention is NOT a rapalog ‚Äî
        it just addresses damage that isn't rate-limiting in rapamycin-treated mice. This intervention
        might still translate to humans if:
      </p>
      <ul class="text-slate-200 space-y-2 ml-4 mb-4">
        <li>‚Ä¢ The damage it addresses IS rate-limiting in humans, OR</li>
        <li>‚Ä¢ The damage hierarchy is different in humans, OR</li>
        <li>‚Ä¢ Humans aren't on rapamycin (so the masking context doesn't apply)</li>
      </ul>
      <p class="text-emerald-300 font-medium">
        Tissue banking and secondary endpoints are critical. Biomarkers, cause-of-death analysis, and
        pathway markers can distinguish overlap from masking ‚Äî and determine whether X is worth pursuing
        for human translation despite showing rX ‚âà r in mice.
      </p>
    </div>

    <!-- What's Missing -->
    <div class="bg-amber-50 rounded-xl border border-amber-200 p-6 mb-6">
      <h2 class="text-xl font-bold text-amber-800 mb-4">What Might Be Missing?</h2>
      <p class="text-slate-700 mb-4">
        Additional explanations that may not be fully captured in the categories above:
      </p>

      <div class="space-y-4">
        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-amber-100 rounded-full flex items-center justify-center text-amber-600 font-bold text-sm">1</div>
          <div>
            <h4 class="font-semibold text-slate-800">Hormetic Dose-Response</h4>
            <p class="text-sm text-slate-600">
              X's benefit might depend on a specific dose window (hormesis). In combination with r,
              the effective "stress" or "signal" level might be pushed outside this optimal window ‚Äî
              either too much total stress or the wrong type of stress response.
            </p>
          </div>
        </div>

        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-amber-100 rounded-full flex items-center justify-center text-amber-600 font-bold text-sm">2</div>
          <div>
            <h4 class="font-semibold text-slate-800">Feedback Regulation</h4>
            <p class="text-sm text-slate-600">
              X's target might be under homeostatic control. r might trigger compensatory feedback
              mechanisms that counteract X's effect ‚Äî not through shared pathways, but through
              regulatory crosstalk.
            </p>
          </div>
        </div>

        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-amber-100 rounded-full flex items-center justify-center text-amber-600 font-bold text-sm">3</div>
          <div>
            <h4 class="font-semibold text-slate-800">Sex-Specific Interactions</h4>
            <p class="text-sm text-slate-600">
              The masking vs overlap pattern might differ by sex. RMR1 showed the r+T requirement
              existed only in males ‚Äî females showed independent effects. The category of explanation
              might itself be sex-dependent.
            </p>
          </div>
        </div>

        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-amber-100 rounded-full flex items-center justify-center text-amber-600 font-bold text-sm">4</div>
          <div>
            <h4 class="font-semibold text-slate-800">Timing / Temporal Interactions</h4>
            <p class="text-sm text-slate-600">
              X might need to act at a specific life stage or within a specific temporal window.
              If r alters the aging trajectory (shifting when different damage types become relevant),
              X's optimal intervention window might shift or close entirely.
            </p>
          </div>
        </div>

        <div class="flex gap-4 items-start">
          <div class="flex-shrink-0 w-8 h-8 bg-amber-100 rounded-full flex items-center justify-center text-amber-600 font-bold text-sm">5</div>
          <div>
            <h4 class="font-semibold text-slate-800">Epiphenomenal Effects</h4>
            <p class="text-sm text-slate-600">
              X's measured effect on damage A might be real but epiphenomenal ‚Äî X doesn't actually
              extend lifespan through reducing A, but through some other unmeasured effect that happens
              to correlate with A reduction. In the r context, that unmeasured effect might be absent.
            </p>
          </div>
        </div>
      </div>
    </div>

    <!-- Implications for Framework -->
    <div class="bg-white rounded-xl shadow-sm border border-slate-200 p-6 mb-6">
      <h2 class="text-xl font-bold text-slate-800 mb-4">Implications for the RMR2 Framework</h2>

      <div class="space-y-4">
        <div class="bg-emerald-50 rounded-lg p-4 border border-emerald-200">
          <h4 class="font-semibold text-emerald-800 mb-2">Secondary Endpoints Become Diagnostic</h4>
          <p class="text-sm text-slate-700">
            Tissue banking and functional assessments aren't just "nice to have" ‚Äî they're essential
            for distinguishing overlap from masking. If rX shows improved A-biomarkers vs r (even with
            same lifespan), that's evidence for masking, not overlap.
          </p>
        </div>

        <div class="bg-purple-50 rounded-lg p-4 border border-purple-200">
          <h4 class="font-semibold text-purple-800 mb-2">Cause-of-Death Data is Critical</h4>
          <p class="text-sm text-slate-700">
            Necropsy and histopathology data can directly test the rate-limiting damage hypothesis.
            If r-treated mice die from damage type C (not A or B), and X addresses A, that explains
            why X doesn't add ‚Äî and suggests X might work in contexts where A is rate-limiting.
          </p>
        </div>

        <div class="bg-amber-50 rounded-lg p-4 border border-amber-200">
          <h4 class="font-semibold text-amber-800 mb-2">rX ‚âà r Is Not Sufficient to Abandon X</h4>
          <p class="text-sm text-slate-700">
            We explicitly note that rX ‚âà r is <strong>not sufficient</strong> to
            classify X as a "functional rapalog" or exclude it from further consideration. Additional evidence
            (pathway markers, biomarkers, cause-of-death) is needed to distinguish overlap from masking.
          </p>
        </div>
      </div>
    </div>

    <!-- Footer -->
    <div class="mt-8 pt-4 border-t border-slate-200">
      <div class="text-center text-xs text-slate-400">
        LEV Foundation | RMR2 Phased Study Design & Analysis Framework | February 2026
      </div>
    </div>

    </div>
  </div>

  <!-- Tab switching script -->
  <script>
    function showTab(tabName) {
      // Hide all tabs
      document.querySelectorAll('.tab-content').forEach(tab => {
        tab.classList.remove('active');
      });
      document.querySelectorAll('.tab-button').forEach(btn => {
        btn.classList.remove('active');
      });

      // Show selected tab
      document.getElementById(tabName + '-tab').classList.add('active');
      event.target.classList.add('active');

      // Scroll to top
      window.scrollTo(0, 0);
    }
  </script>

</body>
</html>
